rfhg_138843.1

Basic information about the TSS

---

TSS ID: rfhg_138843.1 Species: human Chr: chr11		Start: 65209311 End: 65209322 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D2459354,EH38E1544850)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000530567.1:-167 AK025380:-167 GeneID: 823 HGNC/MGI_ID: HGNC:1476 UniProt_ID: Nearer transcript ids and distances: ENST00000533704.1:-361

Gene_name: calpain 1 Gene_symbol: CAPN1 Gene_synonyms: CANP CANPL1 muCANP muCL Gene_source: HGNC:1476

TATA-Box annotation

---

Distance to TSS:	-4524
Nearest PromoterID:	NR_033396
Entrez ID:	440044
Nearest Unigene:	Hs.532372
Nearest Refseq:	NM_001004326
Nearest Ensembl:	ENSG00000197847
Gene Name:	calpain 1
Gene Alias:	Oat6|SLC22A20
Gene Type:	pseudo
CpG%:	0.000000
GC%:	0.333333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CAPN1 p2@CAPN1 p3@CAPN1 p4@CAPN1 p5@CAPN1 p6@CAPN1 p8@CAPN1
Sample		p1@CAPN1	p2@CAPN1	p3@CAPN1	p4@CAPN1	p5@CAPN1	p6@CAPN1	p8@CAPN1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	15.39	2.73	1.95	0.58	0.19	0.39	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	24.08	3.24	1.01	0.00	0.00	0.40	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	19.10	3.47	1.35	0.19	0.00	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.10	2.91	0.42	0.00	0.00	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.32	2.25	1.57	0.00	0.22	0.67	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	14.92	2.13	0.78	0.00	0.00	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	19.61	2.61	1.53	0.00	0.00	0.22	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	19.62	1.94	0.73	0.00	0.24	0.24	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	19.66	4.06	0.85	0.00	0.21	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.75	4.64	1.74	0.00	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.55	2.02	0.40	0.00	0.40	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.82	3.66	0.41	0.41	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	51.26	1.61	1.13	0.64	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	47.36	3.16	0.90	0.60	0.00	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	45.01	1.98	0.66	0.88	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	42.25	2.51	1.01	0.00	0.00	1.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	45.21	3.71	0.44	0.66	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	45.98	3.80	0.42	0.00	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	41.59	3.20	1.60	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	46.04	2.56	0.90	0.60	0.00	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	48.25	2.94	0.13	0.13	0.13	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	46.09	2.59	1.21	0.00	0.00	0.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	43.95	2.84	0.52	0.65	0.13	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	38.34	2.43	1.46	0.97	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	43.34	3.61	0.52	0.52	0.00	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	47.79	1.58	0.63	0.95	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	40.66	1.65	1.10	0.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	48.80	2.59	1.41	1.18	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.51	3.55	0.97	0.65	0.00	0.65	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	36.56	2.17	0.72	0.72	0.00	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	37.05	1.47	0.63	1.47	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	39.86	1.17	0.39	0.20	0.00	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	48.33	3.59	0.63	0.42	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	39.42	1.65	0.82	0.33	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	36.65	2.24	0.37	0.93	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	36.41	1.92	0.19	0.19	0.00	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	38.63	3.68	1.02	0.82	0.00	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	37.68	1.81	0.60	0.00	0.00	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	45.92	3.24	0.54	0.54	0.00	1.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	33.85	2.40	0.96	0.96	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	36.70	3.29	0.24	0.24	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	35.72	1.90	0.59	0.00	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	37.12	2.11	0.84	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	45.63	1.57	0.52	1.05	0.00	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	43.17	2.41	0.00	0.80	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	46.53	2.56	0.23	0.47	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	43.66	2.64	0.48	0.48	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	37.85	1.79	1.79	0.89	0.00	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	44.52	2.63	0.24	0.48	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	42.87	3.44	0.61	0.00	0.00	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	51.44	3.07	0.82	0.41	0.00	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	52.93	4.89	0.44	0.44	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	50.74	2.84	0.35	0.71	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	41.09	2.65	0.33	0.66	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	17.62	0.84	0.84	1.68	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.96	2.76	0.92	0.00	0.00	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	41.49	1.62	0.00	1.30	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	34.37	2.25	0.64	1.28	0.00	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	24.20	2.83	1.26	0.63	0.00	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	56.40	5.64	0.00	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	47.67	5.61	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	18.31	0.00	1.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	30.92	2.04	0.00	0.34	0.00	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	39.64	2.92	0.00	0.97	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	43.66	3.55	0.00	0.00	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	53.63	2.44	0.49	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	51.07	1.49	0.00	0.50	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	38.94	2.35	0.00	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	34.11	3.31	0.00	0.66	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	46.71	0.62	0.00	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	47.70	1.83	0.00	0.61	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	72.54	4.75	1.90	1.58	0.00	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	49.57	3.37	1.12	1.44	0.00	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	52.54	4.83	0.76	1.15	0.13	0.38	0.00
Adipocyte - omental, donor2	11474-119C7	43.35	4.48	1.49	2.99	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	35.50	4.02	0.67	1.00	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	36.37	3.19	1.91	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	17.59	4.40	0.00	1.10	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	45.16	3.61	1.81	1.35	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	35.80	2.61	1.04	2.09	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	49.09	3.72	2.35	1.37	0.20	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	28.83	1.29	0.77	0.77	0.26	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	51.29	1.39	0.56	1.12	0.00	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	37.62	5.29	1.18	1.76	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	31.85	7.32	1.37	3.46	0.00	0.32	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	38.41	2.58	0.32	0.97	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	33.59	8.53	0.53	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	33.39	7.23	4.45	1.11	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	25.37	5.82	2.08	2.50	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	29.39	7.03	3.52	2.01	0.00	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	31.74	5.56	0.98	0.98	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	18.27	3.35	1.22	1.52	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	183.21	4.20	4.86	0.66	2.21	0.00	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	285.43	5.38	4.30	1.08	5.38	0.00	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	100.63	1.20	1.20	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	143.38	4.68	2.16	1.08	2.52	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	148.94	3.35	1.67	0.00	0.00	5.02	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	184.90	4.52	2.05	0.41	1.44	0.21	0.62
Anulus Pulposus Cell, donor1	11248-116E6	95.09	7.78	4.92	0.69	0.11	0.69	0.23
Anulus Pulposus Cell, donor2	11463-119B5	62.21	9.80	2.45	1.22	0.00	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	68.29	1.80	1.80	1.80	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	82.05	2.60	0.87	1.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	72.77	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	74.13	4.18	0.30	2.09	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	89.79	1.26	0.00	0.00	0.00	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	76.57	1.32	0.66	0.66	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	68.55	2.27	1.30	1.30	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	64.56	2.91	0.49	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	80.17	4.75	0.00	2.38	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	63.65	2.64	1.51	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	65.31	0.00	0.73	2.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	68.96	3.76	2.51	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	85.50	4.94	0.99	1.98	0.16	0.16	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	70.97	0.00	2.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	63.33	3.47	0.45	1.06	0.30	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	69.12	1.61	1.07	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	74.82	5.10	0.57	1.89	0.19	0.00	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	74.84	2.67	0.27	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	50.72	1.95	1.95	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	70.66	3.32	0.83	2.49	0.00	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	93.66	0.00	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	49.56	3.54	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	60.38	3.60	1.89	1.03	0.00	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	68.93	2.43	0.00	3.40	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	75.51	5.31	0.00	1.90	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	79.95	2.42	0.00	2.42	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	61.56	3.42	0.57	2.28	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	71.83	5.56	0.43	1.07	0.00	0.00	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	70.46	2.84	0.77	1.55	0.00	0.00	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	54.90	3.28	0.47	1.41	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	73.31	4.82	0.64	1.61	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	72.06	2.14	0.00	0.71	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	59.67	4.68	0.58	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	71.96	2.11	0.30	0.30	0.60	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	80.78	4.75	1.19	1.19	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	74.25	2.03	0.00	2.03	0.51	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	65.71	4.33	1.02	1.27	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	69.26	1.91	1.91	1.27	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	72.50	3.45	0.43	0.86	0.43	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	82.35	3.39	0.42	1.06	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	69.02	3.77	0.58	1.74	0.00	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	73.69	4.72	2.83	1.89	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	67.81	4.41	0.68	1.02	0.17	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	83.39	4.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	61.26	0.00	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	65.82	3.86	0.21	1.07	0.64	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	90.25	5.41	0.60	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	65.61	4.37	0.00	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	70.80	5.06	0.00	1.84	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	0.00	0.00	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	58.47	2.80	0.25	1.27	0.25	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	77.00	4.13	0.21	2.48	0.21	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	66.40	4.59	0.00	0.61	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	69.31	3.35	0.00	1.91	0.48	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	65.19	5.10	1.11	0.67	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	42.72	4.58	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	72.01	1.66	0.55	1.11	0.00	1.11	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	68.32	3.18	0.26	2.12	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	61.79	4.00	1.09	1.45	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	60.79	14.98	5.53	1.35	0.12	0.86	0.74
Astrocyte - cerebellum, donor2	11580-120F5	82.50	11.47	4.11	0.51	0.00	1.71	0.17
Astrocyte - cerebellum, donor3	11661-122F5	55.58	12.17	3.57	0.21	0.00	0.84	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	48.45	9.06	3.14	0.70	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	44.00	5.34	3.40	0.32	0.00	0.32	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	48.18	4.03	2.98	0.60	0.00	0.89	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	44.15	2.29	3.90	0.69	0.00	1.38	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	38.59	2.63	3.51	0.38	0.00	0.88	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	39.94	3.41	2.16	0.11	0.00	0.80	0.11
Basophils, donor1	12241-129G9	37.66	1.83	0.78	0.00	0.00	2.62	0.00
Basophils, donor2	12242-129H1	37.88	1.08	1.08	0.00	0.00	2.89	0.00
Basophils, donor3	12243-129H2	59.39	2.65	0.88	0.73	0.00	2.65	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	217.33	2.59	5.39	0.86	6.25	0.00	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	326.43	4.11	8.23	1.83	5.94	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	143.47	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	231.60	5.65	5.65	1.88	2.51	0.00	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	238.94	3.12	3.74	1.04	3.95	1.25	1.87
Bronchial Epithelial Cell, donor6	11461-119B3	158.44	2.99	5.07	0.92	3.22	1.15	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	86.01	0.72	3.06	0.18	0.36	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	28.75	5.05	2.06	0.10	0.00	1.55	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	28.18	3.73	2.79	0.00	0.00	0.93	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	62.68	3.52	1.28	0.32	0.00	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	60.30	2.25	1.13	0.00	0.00	2.82	0.00
CD14+ Monocytes, donor2	11305-117B9	48.26	3.71	0.93	0.19	0.00	2.04	0.00
CD14+ Monocytes, donor3	11381-118B4	61.03	3.51	1.76	0.44	0.00	1.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	93.69	6.51	1.98	2.26	0.00	1.42	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	79.61	7.20	0.76	2.27	0.00	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	86.79	5.92	0.33	0.66	0.00	1.97	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	40.47	4.34	1.45	0.14	0.00	1.30	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	17.20	2.41	0.91	0.00	0.00	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	27.01	3.32	0.24	0.00	0.00	1.42	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	26.28	1.00	0.50	0.33	0.00	1.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	13.52	1.66	0.55	0.00	0.00	1.38	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	15.37	3.22	0.99	0.25	0.00	1.24	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	19.19	2.15	0.59	0.00	0.00	1.57	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.91	1.60	0.71	0.18	0.00	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	20.89	1.74	0.44	0.22	0.00	1.09	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	25.99	2.11	0.47	0.70	0.00	1.40	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	20.07	1.58	1.06	0.00	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	17.75	1.11	0.00	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	30.34	3.12	1.04	0.00	0.00	0.89	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	17.96	1.40	0.60	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	20.61	1.67	0.83	0.21	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	18.53	1.83	0.69	0.46	0.00	1.37	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	13.12	0.90	1.36	0.23	0.00	0.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.60	0.87	0.44	0.00	0.00	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	34.16	3.23	0.81	0.00	0.00	0.81	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	24.08	2.27	1.40	0.17	0.00	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.04	2.10	0.84	0.00	0.00	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	17.82	1.29	1.10	0.18	0.00	1.47	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	9.51	0.70	0.35	0.00	0.00	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.09	0.88	0.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	21.45	1.05	0.70	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	20.44	2.23	0.74	0.00	0.00	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	28.24	2.80	1.72	0.22	0.00	1.72	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.88	2.87	2.46	0.00	0.82	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.84	1.62	0.46	0.00	0.00	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.38	1.62	1.16	0.00	0.00	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	51.00	3.27	1.53	0.44	0.00	1.09	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	57.98	1.85	1.15	0.23	0.00	1.15	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	54.15	2.38	0.87	0.22	0.00	1.08	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	106.05	5.92	2.02	0.31	0.00	1.56	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	79.46	5.59	2.10	0.70	0.00	1.92	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	63.32	4.91	1.56	0.22	0.00	1.34	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	37.77	1.79	0.77	0.26	0.00	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	39.52	1.54	0.88	0.22	0.00	1.54	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	39.16	1.47	0.63	0.63	0.00	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	36.58	8.13	8.13	0.00	0.00	6.10	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	33.90	4.75	7.46	1.36	0.00	9.49	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	41.42	7.25	7.25	0.00	0.00	10.36	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	33.58	5.86	9.06	0.00	0.00	6.40	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	38.60	11.26	9.11	0.00	0.00	10.72	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	28.78	7.72	8.42	0.00	0.00	7.02	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	34.51	9.41	10.98	0.00	0.00	11.77	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	1.32	6.59	0.00	0.00	6.59	0.00
CD19+ B Cells, donor1	11544-120B5	23.01	12.33	4.93	0.00	0.00	7.40	0.00
CD19+ B Cells, donor2	11624-122B4	18.86	7.98	7.98	0.00	0.00	9.43	0.00
CD19+ B Cells, donor3	11705-123B4	18.68	4.04	2.52	0.00	0.00	6.56	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	124.45	0.40	1.62	0.40	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	123.44	0.80	1.20	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	61.25	5.02	1.00	1.00	0.00	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	29.21	5.62	0.56	0.00	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	90.93	2.63	0.75	0.00	0.00	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	73.51	4.06	0.23	0.23	0.00	1.13	0.23
CD4+ T Cells, donor1	11225-116C1	46.77	0.36	1.43	0.00	0.00	2.50	0.00
CD4+ T Cells, donor2	11306-117C1	47.15	0.61	0.00	0.00	0.00	4.90	0.00
CD4+ T Cells, donor3	11382-118B5	63.13	0.61	0.91	0.00	0.00	3.35	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	85.50	1.53	4.34	0.00	0.00	4.59	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	86.92	0.67	3.82	0.00	0.00	5.84	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	93.71	2.30	3.45	0.00	0.00	4.89	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	38.40	0.95	0.95	0.00	0.00	6.64	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	31.60	0.00	1.40	0.00	0.00	4.92	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	99.28	1.16	2.75	0.14	0.00	1.73	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	95.07	1.02	2.20	0.17	0.00	3.39	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	78.18	0.16	2.10	0.16	0.00	2.10	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	65.90	0.00	2.69	0.00	0.00	4.03	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	75.12	1.40	5.24	0.00	0.00	4.19	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	54.56	1.32	6.16	0.00	0.00	2.64	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	88.12	3.37	3.37	0.00	0.00	2.95	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	76.04	2.49	1.04	0.00	0.00	2.49	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	74.18	1.67	0.33	0.00	0.00	2.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	63.09	0.27	1.90	0.00	0.00	3.81	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	58.42	0.54	2.14	0.00	0.00	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	73.52	0.00	0.00	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	111.07	2.41	1.85	0.00	0.00	3.15	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	77.12	1.73	2.38	0.22	0.00	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	91.42	2.73	3.15	0.00	0.00	2.31	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	59.16	0.51	3.03	0.00	0.00	2.53	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	61.09	1.30	2.17	0.00	0.00	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	45.76	3.05	2.61	0.00	0.00	4.79	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	73.24	1.98	1.98	0.00	0.00	2.47	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	56.31	2.77	0.92	0.00	0.00	3.69	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	0.00	1.40	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	50.68	3.05	4.15	0.28	0.00	2.49	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	60.61	3.44	3.93	0.49	0.00	5.64	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	75.46	0.00	1.54	1.54	0.00	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	85.95	2.15	3.22	0.00	0.00	3.94	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	81.71	1.38	1.38	0.00	0.00	6.92	0.00
CD8+ T Cells, donor1	11226-116C2	52.06	2.62	2.62	0.33	0.00	5.24	0.00
CD8+ T Cells, donor2	11307-117C2	43.93	1.50	1.13	0.38	0.00	2.63	0.00
CD8+ T Cells, donor3	11383-118B6	48.48	1.01	2.52	0.00	0.00	3.79	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	21.10	1.15	0.92	0.00	0.00	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	22.53	1.20	1.20	0.00	0.00	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.71	1.37	0.27	0.00	0.00	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	19.81	0.60	1.50	0.00	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	19.44	0.96	0.24	0.00	0.00	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	19.56	4.09	1.14	0.23	0.00	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	24.55	2.39	1.09	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	27.90	1.58	0.00	0.00	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.75	0.94	0.94	0.00	0.00	0.70	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.17	1.21	1.21	0.60	0.00	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	24.69	2.03	0.58	0.29	0.00	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	23.98	1.07	0.80	0.27	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	16.63	1.31	0.44	0.00	0.00	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.77	0.00	0.00	0.46	0.00	0.46	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	13.43	1.49	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	22.33	1.80	0.72	0.00	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	20.72	1.73	0.58	0.00	0.00	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	18.86	1.65	0.00	0.00	0.00	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.94	1.58	1.58	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.68	2.15	0.92	0.31	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.68	1.28	1.28	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.98	1.53	0.00	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	22.46	1.18	0.39	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.15	0.76	0.76	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	10.44	1.61	0.00	0.00	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.29	1.40	0.70	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	2.00	0.00	2.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	47.52	5.48	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	93.88	3.46	0.49	1.48	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	75.87	2.95	0.42	0.53	0.11	0.42	0.21
Chondrocyte - de diff, donor1	11261-116G1	30.85	3.12	2.08	0.69	0.00	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	47.62	4.98	2.84	1.78	0.00	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	44.37	2.50	0.91	1.25	0.00	0.68	0.00
Chondrocyte - re diff, donor2	11339-117F7	24.17	3.58	1.79	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	27.90	2.43	0.81	0.40	0.00	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	60.82	5.97	3.67	0.80	0.11	1.49	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	59.64	3.85	1.50	0.21	0.00	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	49.82	5.40	1.68	0.00	0.18	0.53	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	46.58	4.22	3.58	2.38	0.09	1.19	0.18
Corneal Epithelial Cells, donor1	11526-119I5	234.72	1.76	7.25	0.88	3.95	0.22	1.10
Corneal Epithelial Cells, donor2	11606-120I4	221.83	1.14	7.96	3.41	7.96	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	205.27	2.05	6.65	1.02	4.60	0.00	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	71.82	7.92	2.15	1.32	0.00	0.66	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	68.13	6.94	1.26	3.15	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	69.01	10.35	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	59.39	4.75	1.62	1.84	0.00	1.19	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	98.73	3.76	0.34	0.00	0.00	1.37	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	74.43	0.65	1.31	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	55.65	0.00	0.00	0.00	0.00	2.42	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	108.40	3.17	1.33	0.50	0.00	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	106.79	4.11	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	119.34	3.39	2.55	1.13	0.00	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	132.90	5.11	0.00	0.00	0.00	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	124.78	5.53	1.16	2.33	0.29	0.00	0.87
Endothelial Cells - Artery, donor2	11341-117F9	112.70	2.82	0.94	0.71	0.24	0.71	0.47
Endothelial Cells - Artery, donor3	11413-118E9	128.85	3.68	1.93	1.05	0.00	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	52.09	5.98	3.77	0.66	0.00	1.77	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	48.07	7.00	4.87	1.83	0.00	1.83	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	30.16	3.66	2.26	0.28	0.00	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	73.99	8.62	3.86	2.97	0.00	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	62.48	0.00	7.29	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	77.13	10.21	3.12	0.71	0.00	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	94.43	7.60	0.80	1.60	0.40	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	75.47	4.72	2.10	0.00	0.00	1.57	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	93.81	3.48	1.86	1.24	0.00	0.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	71.70	1.96	1.30	0.65	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	83.41	1.71	1.71	0.37	0.00	0.49	0.37
Endothelial Cells - Vein, donor1	11267-116G7	138.78	6.83	1.14	1.14	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	197.68	6.29	3.49	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	133.93	3.77	1.88	0.31	0.31	0.16	0.00
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	44.56	0.00	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	46.37	0.00	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	189.84	3.18	7.09	0.49	2.20	0.24	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	81.13	0.00	10.40	2.08	2.08	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	146.42	0.00	16.27	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	59.94	2.87	0.41	2.05	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	47.19	1.75	0.44	2.08	0.11	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	65.87	2.17	0.54	1.08	0.11	0.11	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	93.26	3.27	0.61	1.21	0.00	0.00	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	120.23	2.32	0.96	3.14	0.55	0.27	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	75.62	2.64	0.84	1.79	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	84.84	3.16	1.05	1.32	0.00	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	120.59	2.99	1.33	0.66	0.00	0.00	1.33
Fibroblast - Cardiac, donor1	11268-116G8	73.94	5.90	0.00	0.45	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	115.21	5.31	0.76	0.76	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	59.14	3.79	1.42	0.95	0.16	0.95	0.32
Fibroblast - Cardiac, donor4	11452-119A3	66.38	2.12	0.61	2.12	0.00	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	64.09	3.30	0.51	1.40	0.13	0.51	0.00
Fibroblast - Cardiac, donor6	11460-119B2	68.37	3.34	0.30	1.06	0.15	0.00	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	43.01	8.98	2.41	0.94	0.00	0.54	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	40.12	7.77	3.02	0.86	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	46.87	4.39	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	55.12	3.00	3.23	0.23	0.00	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	100.75	7.63	2.37	0.51	0.17	1.19	0.17
Fibroblast - Dermal, donor1	11269-116G9	68.79	3.99	2.58	1.88	0.00	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	74.05	0.94	3.77	2.36	0.47	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	93.93	3.38	1.81	1.33	0.00	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	40.47	1.24	2.26	0.45	0.23	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	37.16	0.70	1.22	0.52	0.00	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	41.26	1.95	2.76	0.65	0.00	0.81	0.00
Fibroblast - Gingival, donor1	11237-116D4	84.33	4.79	1.67	3.54	0.21	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	89.87	4.72	1.57	4.72	0.00	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	86.32	2.64	3.16	0.53	0.00	0.53	0.13
Fibroblast - Gingival, donor3	11394-118C8	58.59	1.74	1.55	1.35	0.00	0.68	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	75.84	5.19	1.04	7.27	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	47.05	1.94	0.70	1.23	0.00	0.70	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	104.45	2.65	0.78	2.96	0.00	0.31	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	97.09	4.19	1.62	1.76	0.14	0.14	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	96.69	3.18	2.12	2.82	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	84.38	3.07	0.73	3.22	0.00	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	76.63	3.00	1.23	1.64	0.00	0.55	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	62.20	2.08	1.10	1.21	0.00	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	68.97	4.55	2.79	0.59	0.00	1.32	0.00
Fibroblast - Lung, donor1	11270-116H1	125.06	6.80	4.08	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	67.15	2.98	4.48	0.00	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	109.32	2.32	2.11	1.90	0.00	0.84	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	109.13	5.83	4.17	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	58.74	4.20	0.00	4.20	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	118.95	3.64	1.68	1.68	0.00	0.28	0.56
Fibroblast - Mammary, donor1	11540-120B1	113.67	3.65	2.44	0.41	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	123.82	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	5.96	0.00	5.96	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	87.09	2.91	3.30	0.97	0.00	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	57.94	2.43	2.58	0.61	0.00	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	67.01	1.53	2.75	1.53	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	77.85	2.67	1.91	0.76	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	77.49	3.24	1.62	2.43	0.00	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	51.14	2.55	1.04	1.51	0.00	0.93	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	84.00	3.65	0.77	0.88	0.00	0.11	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	106.88	5.08	3.45	1.42	0.00	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	104.24	4.01	3.34	0.67	0.00	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	67.61	4.35	1.58	0.79	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	109.15	4.56	2.78	1.39	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	42.27	3.55	1.78	1.24	0.00	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	53.61	2.76	1.77	0.99	0.00	0.79	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	115.23	5.42	1.20	1.20	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	54.08	2.37	2.16	1.94	0.00	0.32	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	108.82	6.58	2.78	4.30	0.00	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	73.01	6.07	1.48	1.15	0.00	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	118.70	3.01	1.60	2.01	0.20	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	64.30	2.11	1.21	2.01	0.00	0.30	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	135.10	6.35	3.63	3.63	0.00	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	61.06	3.15	1.33	1.91	0.00	0.50	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	60.17	2.91	2.05	1.54	0.00	0.34	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	98.86	5.58	3.28	2.30	0.00	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	62.95	3.62	1.49	1.28	0.11	0.32	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	97.33	2.36	1.18	0.67	0.00	0.34	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	31.36	1.57	1.73	1.10	0.00	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	105.46	3.49	6.97	5.23	3.49	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	229.01	2.43	3.64	2.08	4.68	0.17	1.91
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	175.14	1.30	2.08	1.04	2.86	0.52	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	175.79	3.58	3.32	0.77	5.11	0.26	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	50.53	22.97	0.77	0.00	6.12	0.77	6.12
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	61.89	17.87	1.28	0.64	8.93	1.91	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	51.63	9.98	1.71	0.86	21.39	0.86	3.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	28.68	18.20	1.10	0.28	3.58	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.97	7.76	1.60	0.00	2.05	0.68	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	52.31	11.89	1.98	0.40	10.50	1.39	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	21.15	14.27	0.00	0.26	2.38	0.53	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.40	12.72	1.96	0.33	2.61	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	45.99	12.38	3.10	0.44	13.27	1.33	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	36.60	9.33	1.84	0.14	14.56	0.71	2.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	34.60	5.42	2.09	0.25	7.88	0.37	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	51.58	6.72	2.69	0.00	16.39	0.54	4.30
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.88	5.95	1.98	0.00	5.20	0.37	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	38.34	5.68	2.21	0.14	6.09	0.69	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	48.59	5.08	1.63	0.20	6.51	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	79.86	4.79	0.91	0.23	5.48	0.00	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	64.53	3.86	2.12	0.00	7.22	0.25	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	81.97	4.37	1.31	0.00	10.71	0.87	1.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	64.12	7.68	0.30	0.00	3.84	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	39.26	3.66	1.11	0.00	3.97	0.64	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	71.94	7.60	2.01	0.00	5.81	0.89	2.46
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	49.20	5.85	0.81	0.20	0.20	1.01	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.55	5.09	1.87	0.17	1.19	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	82.91	7.71	1.15	0.44	4.70	0.27	1.60
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	88.86	8.43	1.35	0.31	0.94	1.04	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	76.85	10.76	1.54	0.00	0.85	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	35.41	5.53	1.77	0.22	0.33	0.66	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	61.73	5.99	1.25	0.17	1.58	0.33	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	57.99	6.33	1.43	0.00	0.82	0.41	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	53.43	8.05	0.83	0.21	0.83	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	32.05	6.00	2.19	0.23	0.23	0.69	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	54.53	3.84	2.00	0.17	0.50	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	63.04	6.39	1.10	0.22	0.22	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	43.66	6.64	1.35	0.37	0.37	1.23	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	52.84	6.97	1.62	0.16	0.81	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	47.15	7.70	0.64	0.00	0.32	2.57	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	45.96	6.44	1.61	0.28	0.19	0.57	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	47.61	6.01	1.58	0.79	0.00	1.42	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	70.85	6.39	3.34	0.91	0.00	1.22	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	50.49	7.21	2.82	0.42	0.31	0.94	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	52.03	3.51	0.66	0.44	0.44	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	64.25	5.05	0.84	0.56	0.00	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	52.40	3.52	1.67	0.83	0.19	0.74	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	82.09	6.69	2.41	0.80	0.00	1.34	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	91.50	4.28	0.77	0.77	0.46	1.38	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	53.63	4.53	2.85	0.52	0.52	0.91	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	66.96	5.96	0.81	0.81	0.27	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	75.77	6.08	2.21	0.18	0.37	1.11	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	78.73	8.11	2.19	0.22	0.00	1.54	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	68.43	3.97	0.99	0.00	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	72.68	6.33	2.11	0.66	0.00	1.19	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	69.61	3.63	1.82	0.40	0.61	1.01	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	96.07	5.85	1.27	0.00	0.00	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	57.33	14.33	4.98	0.20	19.71	1.79	6.37
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	39.75	6.47	2.31	0.31	17.10	1.08	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	41.53	12.27	3.27	0.41	19.84	0.61	4.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	59.46	14.71	2.82	0.00	7.51	1.25	5.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	63.57	16.39	2.26	0.00	11.58	0.85	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	48.89	14.30	1.38	0.46	9.22	0.00	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	7.42	2.47	0.00	4.95	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	48.74	12.76	1.16	0.39	7.35	0.39	5.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	67.39	12.84	0.00	0.00	3.21	0.00	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	10.43	0.00	0.00	10.43	0.00	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	32.87	11.07	1.63	0.33	3.58	0.65	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	39.94	10.30	1.24	0.00	4.12	0.41	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	35.79	9.23	1.68	0.28	4.19	0.28	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	35.30	9.81	0.65	0.00	2.94	0.65	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	27.68	5.87	0.84	0.00	2.52	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	38.17	8.91	0.32	0.00	3.18	0.00	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	42.12	9.51	0.68	0.00	4.76	0.68	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	33.41	14.62	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	33.79	10.31	0.57	0.57	1.72	0.57	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	34.33	8.29	0.59	0.00	0.59	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	38.97	5.08	0.00	0.00	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	33.14	9.53	1.24	0.41	0.41	0.00	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	25.08	13.12	0.46	0.00	1.15	0.46	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	21.07	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	29.98	8.84	0.77	0.00	2.31	0.38	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	34.88	5.54	0.65	0.00	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	33.44	7.36	0.67	0.67	1.34	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	29.67	4.24	0.39	0.00	0.00	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.70	7.53	1.03	0.00	1.71	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	7.45	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	26.42	6.13	0.94	0.00	1.42	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	54.92	9.05	0.00	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	37.13	9.66	0.51	0.00	1.53	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	28.32	9.97	1.20	0.00	1.20	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	28.61	9.87	0.00	0.49	0.00	1.97	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	17.71	3.54	0.00	0.00	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	29.76	11.09	0.58	0.00	1.75	1.75	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	26.33	6.14	0.88	0.00	1.32	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	33.06	3.39	0.85	0.00	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	41.19	5.97	0.60	0.00	0.00	0.60	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	30.57	9.70	0.00	0.00	0.49	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	62.77	2.28	0.00	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	70.69	4.57	3.33	0.42	0.00	1.25	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	173.17	6.75	4.50	0.00	0.00	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	50.75	1.27	2.22	0.63	0.00	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	59.32	5.01	1.67	2.51	0.00	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	26.92	1.16	1.62	1.62	0.00	0.46	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	21.27	2.03	2.19	1.18	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	26.16	1.37	1.82	0.46	0.00	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	26.78	1.97	1.20	0.77	0.00	0.22	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	23.00	1.50	1.07	1.07	0.00	0.64	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	20.45	1.94	1.72	0.86	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	28.89	2.37	1.74	0.75	0.00	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	25.56	1.37	1.89	1.20	0.00	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	22.75	1.60	1.60	0.96	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	57.08	8.39	2.80	0.00	0.00	1.68	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	92.62	3.90	2.16	0.87	0.43	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	95.18	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	147.08	12.35	1.41	1.76	0.35	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	151.11	4.36	0.00	1.45	0.00	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	61.02	2.10	0.17	0.87	0.17	0.00	0.00
Hepatocyte, donor1	11523-119I2	26.63	3.63	4.84	3.63	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	45.25	8.62	8.62	3.23	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	23.31	6.75	3.68	5.52	0.00	3.07	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	39.81	3.92	0.65	0.00	0.00	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	90.36	6.64	2.97	0.52	2.80	0.35	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	60.92	5.08	1.78	0.69	0.14	0.82	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	171.93	9.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	0.00	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	270.83	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	163.36	0.00	0.00	1.38	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	152.66	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	130.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	153.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	164.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	172.18	8.12	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	121.71	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	90.76	3.63	0.00	0.00	0.00	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	191.90	1.32	0.00	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	110.86	3.33	0.00	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	125.72	15.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	113.38	1.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	117.54	3.09	1.55	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	146.00	5.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	178.70	1.61	3.22	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	147.49	4.89	0.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	216.20	2.52	2.52	0.42	0.00	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	135.82	2.41	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	132.03	1.85	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	96.77	3.78	1.89	0.00	0.00	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	128.79	3.63	1.81	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	130.21	3.23	0.00	1.08	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	177.86	1.27	0.00	1.27	1.27	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	150.49	1.91	1.28	0.00	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	176.80	7.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	0.00	0.00	0.00	0.00	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	153.52	2.14	0.00	1.43	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	189.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	187.64	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	101.55	2.16	0.00	0.62	0.00	0.31	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	156.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	138.30	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	135.60	0.70	1.39	0.70	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	214.67	2.21	0.00	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	152.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	137.77	5.23	1.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	193.48	4.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	184.68	6.97	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	156.82	3.20	1.07	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	170.41	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	173.83	2.85	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	155.55	4.60	1.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	145.22	3.03	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	217.30	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	122.66	4.23	3.17	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	189.96	1.71	2.61	0.98	3.75	0.00	1.14
Keratinocyte - epidermal, donor2	11349-117G8	146.99	2.34	4.69	0.59	2.93	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	149.94	0.66	1.99	0.57	1.51	0.09	1.14
Keratinocyte - oral, donor1	11251-116E9	194.46	1.59	4.43	0.68	2.72	0.45	0.57
Keratocytes, donor1	11527-119I6	48.14	0.34	3.44	0.34	0.00	1.03	0.00
Keratocytes, donor2	11607-120I5	132.41	1.17	1.17	0.00	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	37.94	1.19	1.38	0.79	0.00	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	61.54	0.00	2.20	4.40	13.19	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	38.83	1.08	1.08	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	61.24	4.96	3.00	0.46	0.12	1.50	0.35
Lens Epithelial Cells, donor3	11690-122I7	53.58	5.25	1.11	0.50	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	68.30	4.62	4.74	1.90	0.24	1.19	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	56.65	2.79	3.07	0.56	0.00	1.40	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	47.85	4.09	4.41	1.42	0.31	1.57	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	49.47	2.69	2.69	1.08	0.00	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	61.77	3.78	1.26	1.26	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	44.85	2.80	3.56	1.08	0.00	1.19	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	40.63	2.05	1.64	0.41	0.41	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	53.09	3.29	2.78	1.26	0.00	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	48.42	3.66	4.22	0.70	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.55	2.77	1.98	0.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	50.41	3.88	3.10	0.39	0.00	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	56.66	3.89	4.63	0.93	0.00	2.78	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	50.52	2.44	3.48	0.70	0.00	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	59.39	2.39	3.10	0.48	0.00	1.19	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	46.97	1.92	3.30	1.92	0.00	0.55	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	42.19	3.08	2.16	1.54	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	52.37	1.25	2.18	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	49.41	4.76	3.48	1.10	0.18	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	49.04	3.62	1.32	1.32	0.66	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	50.96	3.22	3.22	0.59	0.00	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	61.98	3.73	4.98	1.24	0.00	1.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	52.86	3.39	3.39	0.97	0.00	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	51.70	1.08	2.96	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	43.75	3.94	4.24	1.06	0.15	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	43.55	1.56	0.52	1.04	0.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	47.11	1.88	1.47	0.21	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	48.87	3.31	3.46	0.30	0.00	0.75	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	48.84	4.13	2.75	1.38	0.00	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	58.14	3.57	1.13	0.56	0.19	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	52.59	3.71	3.29	0.85	0.11	1.27	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	43.13	2.42	2.91	0.00	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	51.93	4.63	1.65	0.33	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	53.77	4.96	3.10	1.24	0.12	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	54.79	4.81	1.48	1.85	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	47.44	1.73	1.98	0.74	0.00	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	47.99	3.30	3.02	0.82	0.00	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	39.56	2.89	2.89	1.93	0.00	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	47.17	1.83	3.04	0.61	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	47.87	2.80	3.64	0.42	0.00	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	54.05	3.91	2.49	1.42	0.00	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	57.20	2.91	3.88	0.00	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	62.87	3.58	3.89	1.56	0.00	0.78	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	55.86	2.15	1.07	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	54.55	2.61	0.65	0.98	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	51.32	4.94	5.18	0.47	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	63.11	4.46	4.08	0.37	0.25	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	57.37	2.82	2.56	0.00	0.00	1.28	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	41.17	3.28	2.09	1.19	0.00	2.09	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	147.29	4.53	2.27	0.00	2.27	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	144.99	3.07	1.53	0.77	3.84	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	146.96	8.91	0.74	1.48	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	176.87	9.31	0.85	0.00	2.54	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	146.29	6.33	1.41	0.70	0.70	0.00	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	142.90	1.87	0.00	0.93	1.87	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	127.27	6.18	3.09	2.58	1.55	1.03	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	142.74	9.52	2.38	1.19	3.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	164.22	4.98	2.04	2.04	2.04	0.23	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	119.24	4.36	1.45	0.29	0.87	0.58	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	113.44	8.10	3.60	0.45	1.80	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	211.76	7.59	3.25	1.90	2.44	0.95	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	160.73	6.16	3.59	1.03	1.03	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	122.44	4.94	1.76	0.35	3.18	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	92.62	5.33	2.67	0.67	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	142.12	4.58	1.02	1.53	2.04	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	115.79	7.47	1.60	1.07	1.07	0.53	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	127.16	4.72	3.02	1.51	1.51	0.38	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	139.28	9.82	2.45	1.23	3.07	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	160.64	9.79	2.45	0.82	3.26	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	125.99	4.16	2.08	1.67	1.04	0.21	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	133.40	5.61	1.40	1.12	0.84	0.56	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	159.70	13.39	6.18	0.00	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	120.77	3.19	2.61	0.58	1.45	1.74	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	104.03	4.48	0.60	1.49	1.20	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	120.61	6.09	2.21	0.00	1.11	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	159.42	6.72	1.41	1.77	2.47	1.06	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	122.80	8.48	2.21	0.37	1.48	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	146.21	8.06	1.15	0.00	2.30	0.00	5.76
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	160.02	6.14	2.30	1.15	3.07	0.77	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	144.93	1.70	3.96	1.70	1.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	132.10	7.38	0.82	0.00	2.46	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	162.23	5.87	1.81	3.62	1.81	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	144.35	5.03	2.87	2.15	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	132.95	5.98	2.99	2.99	5.98	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	153.84	6.32	4.09	2.60	1.86	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	135.69	8.61	1.72	0.00	0.43	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	128.44	6.85	1.71	1.71	3.43	1.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	148.26	5.33	2.00	0.67	1.67	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	151.43	7.84	4.22	0.00	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	126.56	7.11	1.42	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	153.99	6.19	2.75	0.34	0.69	0.69	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	132.58	6.98	1.07	0.54	1.61	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	144.10	5.39	4.04	1.35	1.35	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	145.20	4.82	2.22	0.74	2.22	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	132.57	11.63	1.16	0.00	3.49	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	129.04	7.40	3.17	0.00	2.12	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	148.86	3.60	2.80	0.80	1.20	0.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	150.46	8.00	2.18	0.73	2.91	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	162.50	11.50	5.37	2.30	3.07	1.53	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	185.47	8.88	1.97	2.96	3.95	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	150.55	0.94	0.94	0.00	1.88	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	185.54	9.55	6.03	1.01	1.01	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	152.31	4.06	1.35	2.70	2.25	1.35	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	98.10	8.61	0.00	0.00	3.44	3.44	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	156.76	9.80	1.78	2.23	3.56	0.89	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	150.94	8.60	2.74	2.35	1.17	0.78	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	149.10	4.62	1.32	0.66	1.32	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	152.05	6.23	3.63	2.59	1.56	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	151.84	6.56	2.63	3.94	1.31	0.00	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	116.85	4.47	2.24	1.12	1.68	1.12	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	145.30	3.53	2.21	2.65	1.77	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	145.41	8.87	1.93	1.93	1.93	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	112.92	1.52	1.01	0.51	2.53	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	138.90	6.25	0.96	1.92	2.88	0.48	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	144.31	5.57	1.59	1.59	1.99	0.00	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	120.92	6.08	0.61	1.82	1.82	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	104.45	4.84	2.77	2.08	1.38	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	140.22	7.98	1.14	1.90	2.28	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	133.75	6.71	1.55	0.52	3.10	1.03	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	108.84	4.84	3.02	2.42	0.00	0.60	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	136.90	6.65	2.22	1.27	2.85	0.63	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	133.27	4.80	1.60	1.07	0.53	0.00	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	115.51	6.90	4.02	0.57	0.57	1.15	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	159.93	7.71	2.06	0.00	2.06	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	162.69	3.54	0.00	0.00	2.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	145.28	5.11	1.70	0.57	0.57	0.57	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	148.94	6.24	4.58	1.25	0.83	1.25	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	150.34	4.70	0.00	0.78	1.57	0.00	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	123.59	5.85	2.09	0.42	1.67	1.25	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	147.29	4.18	3.25	1.39	0.46	0.93	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	140.50	8.70	1.34	0.00	0.00	2.01	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	133.66	5.88	2.67	0.53	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	155.58	5.66	1.21	1.62	2.42	0.81	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	126.65	10.10	0.92	1.84	3.67	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	132.48	3.56	1.78	2.67	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	171.53	7.98	2.85	1.14	0.57	1.71	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	138.81	7.67	2.30	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	125.30	4.92	2.19	2.19	1.64	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	140.76	7.13	4.45	1.78	0.45	0.45	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	188.73	6.24	2.86	1.30	3.38	1.30	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	134.61	7.29	3.32	3.32	0.66	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	193.31	2.08	2.08	0.00	6.24	0.00	6.24
Macrophage - monocyte derived, donor1	11232-116C8	84.78	4.10	0.46	3.65	0.00	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	51.75	3.85	1.10	2.39	0.00	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	80.09	4.46	1.44	3.28	0.00	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	106.74	2.12	2.12	1.59	3.72	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	173.19	3.01	2.69	1.27	3.01	0.48	1.58
Mallassez-derived cells, donor3	11930-125I4	156.78	2.64	5.14	2.36	3.61	0.00	1.11
Mammary Epithelial Cell, donor1	11273-116H4	116.48	1.89	2.79	0.80	2.59	0.10	1.49
Mammary Epithelial Cell, donor2	11350-117G9	144.77	1.74	2.90	1.16	2.32	0.00	2.03
Mammary Epithelial Cell, donor3	11422-118F9	271.13	2.00	5.99	2.74	5.74	0.50	1.50
Mast cell - stimulated, donor1	11487-119E2	35.25	0.68	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	114.95	2.92	0.11	0.00	0.00	0.43	0.00
Mast cell, donor2	11565-120D8	210.99	10.40	1.19	1.19	0.00	1.19	0.00
Mast cell, donor3	11566-120D9	221.30	9.46	0.23	0.68	0.23	0.23	0.00
Mast cell, donor4	11567-120E1	250.51	7.98	0.35	0.35	0.00	0.89	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	87.49	2.66	0.33	0.33	0.00	0.67	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	94.56	0.58	0.58	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	163.82	4.02	0.34	0.00	0.00	0.46	0.00
Mast cell, expanded, donor8	11941-126A6	174.90	3.85	0.50	0.50	0.17	0.67	0.17
Melanocyte - dark, donor1	11502-119F8	50.35	6.07	9.25	1.89	0.10	2.39	0.10
Melanocyte - dark, donor2	11582-120F7	85.48	2.08	0.35	1.73	0.00	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	79.47	4.93	2.68	1.45	0.00	0.43	0.00
Melanocyte - light, donor1	11274-116H5	94.73	3.53	2.82	1.88	0.00	0.94	0.00
Melanocyte - light, donor2	11351-117H1	169.93	6.82	6.82	2.05	0.00	2.73	0.00
Melanocyte - light, donor3	11423-118G1	101.47	3.47	2.60	1.73	0.87	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	47.27	2.81	1.87	0.73	0.00	0.42	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	79.88	2.69	1.88	0.00	0.27	0.81	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	84.91	7.77	3.21	1.34	0.00	0.80	0.80
Meningeal Cells, donor1	11493-119E8	44.54	5.71	5.33	0.25	0.00	0.50	0.25
Meningeal Cells, donor2	11573-120E7	47.54	9.24	5.28	1.32	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	56.97	3.42	3.42	0.49	0.00	0.90	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	81.84	3.42	2.00	0.57	0.00	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	46.59	2.82	0.40	0.91	0.20	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	190.55	15.77	3.94	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	90.26	3.92	3.92	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	53.10	2.15	2.15	1.44	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	59.51	4.66	2.33	1.48	0.00	1.27	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	69.37	5.03	3.02	0.50	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	97.57	3.52	3.74	0.66	0.00	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	64.29	0.00	1.46	0.73	0.00	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	76.73	3.07	2.25	0.41	0.00	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	45.98	6.37	1.66	0.97	0.14	0.83	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	117.46	5.20	1.12	1.49	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	60.26	1.32	0.79	0.39	0.00	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	75.37	3.86	0.59	1.48	0.00	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	30.36	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	92.86	3.84	2.56	1.28	0.00	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	58.48	2.13	2.48	2.13	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	56.60	0.94	0.31	0.31	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	50.07	0.73	0.00	0.73	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	92.28	2.65	0.27	2.39	0.53	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	63.56	1.50	0.50	0.50	1.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	88.89	2.53	0.14	1.45	0.29	0.07	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	76.97	6.75	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	65.26	5.42	0.74	3.20	0.00	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	66.25	6.77	0.59	1.47	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	96.80	13.83	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	47.11	4.03	0.93	1.55	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	56.21	3.94	0.41	2.28	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	69.48	18.53	0.00	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	63.32	3.00	1.50	0.50	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	68.43	3.26	2.79	1.40	0.00	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	51.41	4.47	1.02	2.44	0.00	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	54.25	3.17	0.79	1.58	0.00	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	62.83	7.08	0.00	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	54.71	3.80	1.52	4.18	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	63.16	1.32	1.32	3.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	43.72	3.40	0.21	2.33	0.00	1.06	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	33.15	7.37	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	39.05	2.38	0.89	2.38	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	41.92	1.68	0.00	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	45.41	3.76	0.25	2.26	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	41.35	2.38	1.19	2.14	0.00	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	39.25	5.53	1.11	3.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	37.07	2.99	1.15	0.46	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	50.69	5.26	0.63	2.10	0.00	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	40.77	2.65	0.61	1.83	0.00	1.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	37.12	3.43	0.21	1.72	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	47.79	2.00	0.67	1.56	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	37.01	4.38	0.88	1.10	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	41.06	2.53	1.01	1.01	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	49.71	1.66	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	32.34	4.08	0.82	1.09	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	53.52	4.41	0.88	1.18	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	53.43	2.18	2.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	34.12	2.40	1.44	1.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	46.43	4.00	3.20	1.20	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	35.65	2.74	1.37	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	42.05	5.51	1.00	1.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	26.50	4.08	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	44.67	3.94	1.31	1.31	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	37.52	3.31	1.10	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	44.83	1.92	1.28	2.56	0.00	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	38.43	2.73	1.74	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	34.79	3.48	3.48	2.09	0.70	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	44.20	4.42	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	61.20	2.74	2.05	1.03	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	52.51	3.50	0.44	2.63	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	39.42	2.13	1.42	4.26	0.00	1.42	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	60.88	4.21	1.40	1.68	0.00	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	57.77	4.16	2.91	1.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	47.79	3.50	0.58	2.33	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	50.68	3.02	1.81	2.41	0.00	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	58.02	4.59	2.92	2.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	44.33	2.77	2.77	0.92	0.00	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	65.45	1.14	1.71	1.14	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	46.57	1.11	1.52	3.18	0.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	60.64	2.85	1.81	2.07	0.00	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	61.77	2.57	4.29	4.72	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	59.71	3.18	1.27	8.26	0.00	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	50.18	2.94	1.33	1.33	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	73.93	3.29	2.39	5.99	0.00	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	38.28	1.70	1.84	3.53	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	59.24	5.73	1.59	3.82	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	83.81	4.20	2.65	3.10	0.00	0.66	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	71.67	3.79	1.52	4.55	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	51.99	2.56	1.99	3.13	0.00	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	71.28	5.90	1.47	4.42	0.00	0.98	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	47.57	3.91	2.61	4.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	47.93	3.23	2.94	3.23	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	68.62	4.90	2.88	4.32	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	69.24	4.53	0.82	4.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	54.79	4.17	2.38	3.87	0.00	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	0.00	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	5.35	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	50.93	3.94	0.66	1.31	0.00	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	58.91	7.36	0.00	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	55.95	6.52	0.59	0.99	0.00	1.98	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	30.73	4.66	0.00	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	59.33	6.76	0.00	1.13	0.00	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	50.07	7.19	0.80	3.20	0.00	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	53.16	4.41	0.90	0.90	0.00	0.57	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	41.26	3.68	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	50.93	3.66	0.37	1.83	0.00	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	3.11	0.00	3.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.03	0.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	57.57	3.03	3.03	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.35	4.64	0.84	0.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	0.00	0.00	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	57.09	5.60	1.94	0.86	0.00	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	45.47	8.88	0.00	0.00	0.00	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	56.74	4.00	0.67	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	64.69	5.84	0.83	0.83	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	33.08	4.56	3.80	0.57	0.00	0.76	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	76.60	6.38	3.19	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	55.08	2.72	2.04	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	0.00	0.00	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	51.90	6.70	0.42	0.84	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	63.46	6.51	0.70	0.46	0.00	0.46	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	48.64	5.94	0.27	0.27	0.00	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	50.88	5.89	0.84	0.63	0.00	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	66.51	6.45	0.99	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.17	5.14	1.35	1.08	0.00	1.08	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	56.44	4.76	0.45	0.68	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	43.11	5.23	0.49	0.33	0.00	0.65	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	42.83	4.37	1.64	0.91	0.00	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	54.63	6.90	0.00	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	49.23	5.40	0.60	0.00	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.03	3.61	1.97	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	43.75	5.04	0.16	0.81	0.00	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	44.45	3.17	0.88	1.59	0.00	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	45.71	5.63	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	43.67	4.14	0.92	0.46	0.00	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	39.85	7.71	0.32	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.73	1.38	3.79	0.69	0.00	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	0.00	10.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	34.09	4.23	0.89	0.22	0.00	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	27.52	2.96	1.69	0.85	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.72	2.37	0.47	0.71	0.00	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	36.92	6.01	0.00	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	48.98	4.33	1.33	1.67	0.00	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.54	2.25	0.90	0.45	0.00	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.46	4.36	0.40	0.40	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	37.15	6.50	0.00	1.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	26.49	4.54	0.76	0.76	0.00	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	31.94	4.89	0.33	0.98	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	32.25	3.05	0.44	0.44	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.07	2.71	0.90	0.45	0.00	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	31.75	7.06	0.88	0.00	0.00	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	37.23	3.32	0.00	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	40.18	5.46	0.50	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	26.03	4.21	0.38	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	31.76	5.14	1.81	0.30	0.30	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.30	4.86	0.88	0.22	0.00	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	24.40	5.42	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	42.68	3.66	0.61	1.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.92	6.29	0.00	0.31	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.03	2.12	0.61	0.91	0.00	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.85	4.75	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	18.14	2.27	2.27	0.00	0.00	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	0.00	5.06	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	59.38	2.73	2.11	1.24	0.12	0.12	0.75
Myoblast, donor2	11322-117D8	69.62	3.84	1.34	1.15	0.00	0.19	0.00
Myoblast, donor3	11398-118D3	56.33	4.20	1.85	2.02	0.17	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	19.99	3.65	1.90	0.00	0.00	1.75	0.00
Natural Killer Cells, donor1	11230-116C6	53.20	3.38	4.31	0.00	0.00	4.61	0.00
Natural Killer Cells, donor2	11311-117C6	51.26	3.02	1.21	0.00	0.00	3.32	0.00
Natural Killer Cells, donor3	11387-118C1	54.30	2.76	2.58	0.18	0.00	2.76	0.00
Neural stem cells, donor1	11275-116H6	37.75	8.35	3.27	0.00	0.00	0.36	0.36
Neural stem cells, donor2	11352-117H2	55.84	1.93	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	27.31	5.69	2.28	0.00	0.00	3.41	1.14
Neurons, donor2	11574-120E8	52.40	9.25	1.98	1.10	0.44	1.54	0.44
Neurons, donor3	11655-122E8	21.38	5.76	0.00	0.00	0.82	1.64	0.00
Neutrophils, donor1	11233-116C9	94.66	1.86	3.71	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	55.08	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	142.33	4.89	2.44	0.61	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	77.06	4.99	2.85	0.47	0.00	1.90	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	92.80	5.54	2.28	0.33	0.00	1.30	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	38.31	4.01	2.21	0.40	0.00	1.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	39.78	3.17	0.28	1.24	0.00	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	48.20	3.47	0.43	1.16	0.00	0.58	0.14
Olfactory epithelial cells, donor3	11935-125I9	38.48	3.06	0.34	0.68	0.00	0.34	0.23
Olfactory epithelial cells, donor4	11936-126A1	52.11	1.66	0.78	0.68	0.00	0.88	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	146.24	2.41	0.60	0.60	2.41	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	67.64	6.38	2.55	1.91	0.00	0.85	0.21
Osteoblast - differentiated, donor2	11353-117H3	48.01	9.14	3.43	2.29	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	42.83	3.72	0.62	0.00	0.00	1.86	0.00
Osteoblast, donor1	11277-116H8	115.31	7.62	4.89	2.15	0.00	0.20	0.20
Osteoblast, donor2	11354-117H4	66.72	5.62	4.21	0.70	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	90.82	5.33	2.49	1.07	0.00	0.00	0.36
Pancreatic stromal cells, donor1	11249-116E7	94.09	3.29	1.52	2.11	0.08	0.17	0.34
Pericytes, donor1	11491-119E6	62.75	12.46	4.90	0.78	0.00	1.89	0.56
Pericytes, donor2	11571-120E5	51.84	11.09	4.98	0.23	0.00	2.04	0.00
Pericytes, donor3	11652-122E5	103.56	2.85	0.61	1.63	0.00	1.02	0.41
Perineurial Cells, donor1	11499-119F5	50.07	2.60	2.37	0.34	0.00	0.23	0.11
Perineurial Cells, donor2	11579-120F4	107.93	3.77	0.83	1.66	0.18	0.09	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	75.86	2.87	2.87	0.96	0.00	2.55	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	48.48	1.47	1.47	0.49	0.00	1.22	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	54.48	2.59	2.20	0.39	0.00	3.11	0.00
Placental Epithelial Cells, donor1	11278-116H9	96.14	5.02	2.87	0.72	0.72	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	96.47	6.65	5.54	3.33	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	99.73	4.71	1.18	0.39	1.57	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	43.04	2.22	0.63	1.90	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	62.09	4.13	1.13	0.75	0.00	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	92.15	6.00	1.83	2.22	0.00	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	58.31	4.50	0.90	1.58	0.00	0.00	0.45
Preadipocyte - omental, donor1	11468-119C1	54.24	2.98	0.64	1.49	0.00	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	63.72	4.36	1.75	1.75	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	51.71	3.87	0.57	0.86	0.00	0.14	0.29
Preadipocyte - perirenal, donor1	11469-119C2	55.12	7.87	0.00	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	145.57	4.30	0.61	3.99	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	72.07	3.19	0.53	0.53	0.18	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	81.74	3.75	1.02	1.19	0.00	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	94.73	3.82	1.68	0.93	0.00	0.09	0.28
Preadipocyte - visceral, donor2	11357-117H7	110.90	3.22	0.92	0.92	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	69.38	4.08	0.63	1.04	0.42	0.00	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	58.23	10.56	3.47	0.15	0.45	1.51	0.60
Prostate Epithelial Cells, donor2	11331-117E8	144.22	2.84	2.98	1.49	6.36	0.00	2.57
Prostate Epithelial Cells, donor3	11404-118D9	86.47	0.86	1.29	0.61	3.49	0.18	0.18
Prostate Stromal Cells, donor1	11254-116F3	80.41	2.16	1.03	1.25	0.23	0.23	0.57
Prostate Stromal Cells, donor2	11332-117E9	82.30	3.23	0.36	1.08	0.00	0.00	0.54
Prostate Stromal Cells, donor3	11405-118E1	76.96	4.28	1.15	1.25	0.10	0.73	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	219.72	6.20	5.84	1.09	4.38	0.73	2.55
Renal Cortical Epithelial Cells, donor2	11596-120H3	132.66	3.40	2.91	0.42	2.15	0.49	1.39
Renal Epithelial Cells, donor1	11517-119H5	222.67	8.12	8.12	0.00	1.01	0.51	3.04
Renal Epithelial Cells, donor2	11597-120H4	155.78	9.96	3.56	0.00	2.13	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	120.58	4.76	2.86	0.74	0.74	1.06	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	66.72	8.85	5.45	1.36	0.00	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	75.33	4.18	4.72	1.75	0.00	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	71.71	3.77	2.00	0.67	0.00	0.67	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	55.23	9.32	2.66	0.67	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	179.37	9.46	4.40	0.88	0.22	0.66	0.88
Renal Mesangial Cells, donor2	11598-120H5	139.19	10.66	2.51	0.00	0.63	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	165.89	11.65	2.50	0.83	0.83	1.39	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	250.17	4.03	5.37	1.07	3.76	1.34	2.95
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	175.42	3.37	4.22	0.42	4.22	2.11	2.53
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	176.65	5.01	2.89	0.77	1.54	1.93	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	54.45	3.37	3.11	0.26	0.52	1.30	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	76.75	4.55	2.56	0.28	0.00	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	52.49	8.23	2.06	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	30.61	2.01	1.25	0.00	0.00	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	54.92	5.48	3.21	0.94	1.20	0.67	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.95	1.79	2.68	0.89	0.00	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.31	3.30	1.65	0.00	0.00	3.30	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	18.56	1.74	0.00	1.16	0.00	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	25.88	3.77	1.69	0.39	0.13	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	31.38	2.58	1.79	0.89	0.00	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	42.16	4.02	2.23	0.56	0.00	0.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	28.90	2.48	1.86	0.37	0.00	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	35.55	3.50	0.82	0.70	0.00	0.70	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	39.06	4.85	1.85	0.23	0.00	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	32.86	4.38	1.51	1.51	0.00	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	31.92	3.48	1.21	0.61	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	48.02	2.51	1.25	0.18	0.00	0.72	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	31.13	5.02	0.72	1.00	0.00	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	34.23	2.58	1.93	0.32	0.00	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	33.41	3.54	0.66	1.99	0.00	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	26.76	2.29	1.15	0.57	0.00	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	36.24	3.07	1.30	0.37	0.09	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	31.19	4.32	1.32	0.38	0.00	0.56	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	29.86	4.51	1.06	0.80	0.00	1.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	33.39	3.21	0.97	1.17	0.00	0.97	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	38.57	3.82	1.15	0.38	0.00	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	26.70	2.46	0.85	0.64	0.00	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	31.11	3.08	1.68	0.84	0.00	1.12	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	33.67	1.88	1.03	0.68	0.17	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.26	4.19	1.09	0.91	0.00	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	34.70	2.94	1.47	0.37	0.00	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	35.19	4.57	0.94	0.81	0.00	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	28.07	3.77	1.42	0.47	0.00	1.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	36.11	2.18	1.39	0.60	0.00	1.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	41.86	3.74	0.47	0.94	0.00	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	27.37	4.77	1.45	0.41	0.00	0.62	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	38.49	3.76	1.55	0.00	0.00	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	34.26	2.72	0.84	0.84	0.00	0.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.61	4.31	2.02	0.94	0.00	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	31.85	2.72	1.36	0.68	0.00	1.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	30.85	1.54	2.31	0.58	0.00	0.96	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	31.46	4.64	0.86	0.52	0.00	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	31.27	3.70	0.55	0.82	0.00	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	32.01	3.94	1.15	0.49	0.00	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	38.52	5.62	1.02	0.85	0.00	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	39.95	3.70	1.48	0.89	0.00	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	31.19	4.26	0.80	0.27	0.00	1.33	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	26.27	2.49	1.80	0.55	0.00	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	39.05	3.81	1.67	0.95	0.00	1.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	40.11	3.83	0.60	0.20	0.00	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	39.27	4.61	1.32	0.75	0.00	1.22	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	42.97	3.14	1.75	0.35	0.00	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.92	4.23	0.91	0.00	0.00	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	41.98	3.55	1.35	0.61	0.00	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	62.88	6.70	1.89	0.87	0.00	1.16	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	49.89	3.65	0.00	0.00	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	44.00	3.92	1.81	0.60	0.00	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	56.77	3.85	2.49	0.45	0.00	1.36	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	44.33	3.89	2.70	0.60	0.00	3.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	35.30	3.54	1.53	0.71	0.00	1.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	58.06	6.19	2.35	0.64	0.00	1.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	57.09	4.81	2.40	0.00	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	78.61	6.77	3.76	0.56	0.00	1.13	0.56
Schwann Cells, donor2	11578-120F3	27.22	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	78.21	4.60	3.51	0.88	0.22	1.10	0.00
Sebocyte, donor1	11220-116B5	157.76	2.74	4.93	0.55	2.19	0.00	0.55
Sebocyte, donor2	11301-117B5	127.30	1.38	0.92	0.92	0.92	0.00	3.22
Sebocyte, donor3	11378-118B1	69.05	2.89	1.86	1.65	1.03	0.62	0.41
Sertoli Cells, donor1	11255-116F4	84.49	0.00	0.00	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	93.20	0.00	2.82	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	43.20	3.78	1.23	0.26	0.00	1.14	0.18
Skeletal Muscle Cells, donor2	11358-117H8	56.38	8.67	4.34	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	130.42	5.85	1.67	0.84	0.00	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	38.65	3.14	1.10	0.00	0.00	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	39.54	2.53	1.64	0.59	0.00	0.30	0.45
Skeletal Muscle Cells, donor6	11459-119B1	34.17	2.15	1.54	0.15	0.00	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	75.23	4.79	2.14	0.63	0.13	0.50	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	60.93	4.57	0.71	0.71	0.00	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	51.49	1.79	2.28	0.50	0.10	0.50	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	44.57	6.32	2.86	0.67	0.00	1.01	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	94.81	5.07	1.45	2.90	0.00	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	73.75	14.04	3.44	0.83	0.14	0.69	0.55
Skin - palm, donor1	10286-104F7	56.41	8.06	13.43	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	77.41	1.01	0.86	0.58	1.15	0.00	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	101.42	2.45	2.45	1.64	6.54	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	95.29	1.17	0.91	0.65	0.65	0.26	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	122.19	1.25	2.64	0.97	1.95	0.14	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	86.93	1.27	1.27	0.56	3.24	0.14	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	177.61	2.96	2.33	1.48	5.50	0.00	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	93.99	1.20	1.12	0.90	2.62	0.15	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	71.59	3.09	1.23	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	70.92	2.22	0.00	1.11	0.00	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	148.72	2.35	1.18	4.70	0.00	0.00	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	149.83	3.09	1.33	1.55	0.22	1.10	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	169.72	4.33	1.58	1.58	0.00	0.39	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	157.60	3.86	2.32	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	57.04	5.00	0.00	3.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	124.83	3.86	0.67	2.00	0.00	0.00	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	60.73	1.99	0.22	0.66	0.00	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	57.74	1.79	0.26	2.05	0.00	0.26	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	55.68	5.21	4.56	0.65	0.00	1.30	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	69.40	4.13	1.48	1.18	0.00	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	72.75	2.28	1.42	1.57	0.00	0.43	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	129.00	4.72	4.72	0.81	0.00	0.98	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	42.32	1.83	1.22	0.30	0.00	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	210.13	9.60	0.76	2.53	0.00	0.00	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	97.93	6.12	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	99.18	3.34	1.43	1.43	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	76.39	3.10	2.80	1.18	0.00	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	73.18	3.44	1.51	1.29	0.00	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	76.41	3.15	1.78	0.52	0.21	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	173.86	4.49	1.24	2.63	0.46	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	164.92	3.23	0.00	3.23	0.00	0.00	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	92.65	5.08	0.60	0.90	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	97.98	2.73	3.76	1.02	0.00	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	69.66	2.59	2.04	1.10	0.00	1.02	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	115.33	3.42	0.50	2.42	0.00	0.30	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	113.09	1.59	0.68	2.05	0.23	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	117.14	1.21	2.42	6.64	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	62.26	2.12	2.38	1.06	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	52.33	3.20	1.86	0.80	0.00	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	80.39	2.13	1.00	1.13	0.13	0.13	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	65.19	4.06	1.27	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	246.82	4.07	1.06	2.11	0.45	0.15	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	179.29	3.75	0.00	4.50	0.00	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	201.59	6.46	1.29	1.29	0.00	14.21	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	179.52	5.58	0.47	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	124.71	2.52	1.01	2.52	1.01	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	89.32	2.82	2.19	2.82	0.00	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	94.99	4.13	3.54	4.13	0.00	0.59	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	64.90	2.25	2.00	1.25	0.00	0.25	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	76.15	4.67	3.74	0.93	0.00	2.34	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	117.87	3.02	0.86	1.15	0.00	0.14	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	144.05	3.31	0.76	0.51	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	99.09	3.76	0.94	1.88	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	77.42	2.52	0.98	1.26	0.00	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	96.19	4.78	1.17	1.34	0.00	0.25	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	58.57	0.48	1.90	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	97.13	2.69	0.98	2.20	0.24	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	68.71	2.43	0.88	2.21	0.00	0.00	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	105.33	1.17	1.17	1.46	0.29	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	43.73	2.72	1.75	0.97	0.00	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	49.19	1.59	1.32	0.79	0.00	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	30.50	1.12	1.86	0.74	0.74	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	50.67	1.44	3.95	2.52	0.00	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	59.62	0.85	2.27	0.85	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	50.42	1.18	2.36	1.18	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	24.13	2.29	2.29	1.52	0.00	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	45.92	1.20	2.00	2.80	0.00	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	43.05	1.67	2.09	0.42	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	47.67	2.29	1.38	1.38	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	58.41	2.86	0.67	0.84	0.00	0.00	0.17
Synoviocyte, donor2	11368-117I9	51.46	3.18	0.67	1.51	0.00	0.34	0.00
Synoviocyte, donor3	11440-118H9	38.87	3.57	0.67	1.12	0.00	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	136.86	4.29	2.50	0.71	0.00	0.36	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	55.50	1.98	3.96	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	102.11	4.63	2.78	0.69	0.00	1.39	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	141.72	0.86	3.30	0.43	2.15	0.29	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	233.87	0.39	5.03	1.55	8.50	0.00	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	160.35	1.15	2.86	1.72	5.15	0.00	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	62.25	4.31	2.95	1.23	0.74	0.62	0.98
Urethra, donor2	10319-105A4	84.53	3.60	1.80	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	204.29	3.19	2.39	1.33	3.72	0.27	0.27
Urothelial Cells, donor2	11600-120H7	149.41	0.00	2.80	0.40	4.41	0.40	0.80
Urothelial Cells, donor3	11681-122H7	160.44	1.60	2.98	0.23	3.21	0.00	0.00
Urothelial cells, donor0	11216-116B1	159.82	1.34	2.01	0.45	3.79	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	125.46	1.78	4.45	0.89	0.00	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	131.52	11.44	4.29	0.00	0.00	4.29	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	122.53	4.11	3.42	0.00	0.00	3.42	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	92.63	2.75	2.07	0.00	0.00	2.41	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	126.08	2.32	2.91	0.58	0.00	7.55	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	98.92	3.12	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	98.20	1.84	4.59	0.00	0.00	2.75	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	109.55	3.65	2.74	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	25.04	7.28	1.48	0.49	0.74	0.37	0.99
Wilms' tumor cell line:HFWT	10597-108E3	32.56	7.04	3.52	0.88	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	316.75	3.91	4.75	0.00	8.94	0.84	1.96
achilles tendon, donor2	10292-104G4	26.86	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	41.05	5.10	8.16	0.00	0.00	1.02	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	61.06	6.04	2.79	0.00	0.00	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	32.88	0.36	1.54	0.00	0.00	0.47	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	68.30	0.27	0.27	0.00	0.00	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	64.65	1.41	1.12	0.00	0.00	1.12	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	88.40	2.33	1.27	0.21	0.00	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	138.83	3.81	2.18	0.27	0.00	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	50.23	0.44	0.44	0.00	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	110.26	6.13	0.82	0.41	0.00	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	87.76	9.32	2.33	0.00	0.00	2.33	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	32.57	0.00	0.55	0.00	0.00	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	117.02	15.60	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	102.25	6.27	1.63	0.23	0.00	1.63	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	60.84	1.81	0.52	0.52	0.00	1.04	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	65.75	4.38	0.58	0.00	0.00	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	59.95	1.39	0.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	64.98	3.70	0.82	0.41	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	62.31	5.22	0.92	0.61	0.00	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	53.34	3.84	1.28	0.85	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	79.77	3.03	0.91	0.00	0.00	1.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	67.64	2.89	0.48	0.96	0.00	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	36.31	0.67	1.11	0.45	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	103.40	1.67	0.33	0.33	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	91.05	3.72	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	157.07	1.88	0.00	0.00	1.51	0.00	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	77.63	4.36	0.00	0.00	0.00	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	80.60	1.87	1.87	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	63.82	2.12	1.41	2.35	0.47	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	57.55	3.88	1.86	0.78	0.00	0.62	0.16
adipose, donor1	10184-103D4	7.62	6.45	0.59	0.00	2.93	0.59	0.00
adipose, donor2	10185-103D5	23.52	14.19	0.00	0.00	1.22	0.00	0.00
adipose, donor3	10186-103D6	38.12	10.35	1.09	0.00	1.91	0.00	0.54
adipose, donor4	10187-103D7	66.74	11.27	1.73	0.00	5.20	1.73	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	28.41	13.57	1.42	1.26	0.32	0.47	0.16
adrenal gland, adult, pool1	10081-102A9	25.46	3.64	3.64	14.55	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	26.15	0.80	0.80	0.00	0.00	1.07	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	50.74	7.86	0.36	0.00	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	118.24	1.62	0.70	0.93	1.39	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	109.88	2.70	1.69	0.68	1.35	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	77.48	2.36	1.18	0.88	1.18	0.88	0.00
amygdala - adult, donor10196	10167-103B5	15.42	4.74	1.19	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	26.77	4.87	2.84	1.01	0.41	0.61	0.20
amygdala, newborn, donor10223	10360-105E9	13.56	5.16	1.94	1.94	0.97	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	69.52	2.93	0.64	0.38	0.00	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.08	1.54	1.32	0.44	0.22	0.88	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	45.76	12.36	2.00	0.00	4.68	1.00	0.00
aorta, adult, pool1	10052-101G7	35.89	2.35	0.59	0.59	0.20	0.98	0.39
appendix, adult	10189-103D9	84.22	5.82	4.27	1.94	0.39	1.55	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	33.36	6.88	0.00	0.34	0.00	0.34	0.34
artery, adult	10190-103E1	32.61	5.43	1.36	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	92.86	8.11	1.74	0.87	0.43	1.59	0.00
b cell line:RPMI1788	10427-106D4	26.47	2.53	2.97	0.00	0.00	1.49	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	86.01	3.05	1.39	2.77	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	200.25	2.18	2.18	1.39	6.55	0.00	1.39
bile duct carcinoma cell line:TFK-1	10496-107C1	37.16	1.17	1.51	0.67	2.01	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	50.89	1.68	0.56	0.00	0.00	1.12	0.00
bladder, adult, pool1	10011-101C2	65.95	1.20	2.50	0.87	0.87	0.76	0.00
blood, adult, pool1	10053-101G8	48.72	4.43	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	74.50	3.43	1.71	1.71	0.00	0.86	0.00
bone marrow, adult	10192-103E3	42.51	6.07	2.02	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	30.75	3.08	0.00	4.10	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	29.29	5.23	1.56	4.79	1.00	0.22	0.22
brain, fetal, pool1	10085-102B4	56.10	18.70	8.01	8.01	0.00	5.34	2.67
breast carcinoma cell line:MCF7	10482-107A5	96.80	7.27	1.98	0.99	1.98	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	82.13	7.24	0.75	1.37	1.37	0.37	0.25
breast, adult, donor1	10080-102A8	39.78	3.79	0.00	0.63	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	155.37	3.30	1.78	0.89	8.77	0.51	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	93.38	7.73	3.40	0.00	2.78	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	42.36	7.60	2.07	0.92	0.00	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	54.47	5.81	1.69	0.48	0.24	1.45	0.00
carcinoid cell line:NCI-H1770	10703-109H1	29.15	2.35	6.58	0.00	3.29	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	51.96	6.13	1.64	1.42	0.44	0.55	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	6.34	0.63	0.32	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	23.96	2.40	0.53	0.53	0.00	1.33	0.00
caudate nucleus - adult, donor10196	10177-103C6	17.27	0.00	0.00	3.45	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	30.45	3.85	1.17	3.35	1.00	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	24.45	2.29	0.76	10.70	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	21.97	4.39	0.37	2.56	0.73	0.00	1.46
cerebellum - adult, donor10196	10173-103C2	20.39	0.00	0.00	2.91	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	46.76	4.06	2.35	1.28	8.54	0.43	0.00
cerebellum, adult, pool1	10083-102B2	26.22	2.76	0.34	0.00	6.21	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	42.34	9.96	5.81	1.66	12.45	0.83	0.00
cerebral meninges, adult	10188-103D8	24.46	4.29	1.26	3.78	2.77	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	24.12	1.46	1.46	0.73	0.73	3.65	0.00
cervical cancer cell line:D98-AH2	10552-107I3	18.26	2.30	2.30	0.86	0.00	0.72	0.00
cervical cancer cell line:ME-180	10553-107I4	156.10	5.30	10.11	0.66	8.78	0.50	0.83
cervix, adult, pool1	10013-101C4	86.09	6.19	4.41	0.84	1.99	0.94	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	22.29	1.67	0.14	1.11	0.00	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	22.21	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	98.55	5.22	2.11	0.00	5.10	0.25	0.75
choriocarcinoma cell line:SCH	10785-110H2	54.58	4.56	0.86	0.12	1.60	0.12	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	55.74	2.61	0.95	0.24	2.13	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	99.44	2.28	0.57	0.85	0.85	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	109.47	2.88	1.79	1.09	0.89	0.40	0.50
chorionic membrane cells, donor3	12240-129G8	91.21	2.75	1.65	1.10	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	55.54	0.00	0.00	0.00	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	62.24	3.65	0.19	0.19	0.00	0.96	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	164.09	3.17	0.00	0.42	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	63.94	1.28	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	69.42	1.94	0.24	0.48	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	71.67	0.61	0.41	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	135.74	2.06	0.29	0.00	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	198.60	3.13	1.04	0.00	0.00	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	55.77	6.40	0.91	0.23	0.23	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	79.99	6.42	1.04	0.35	3.30	1.04	0.52
colon carcinoma cell line:CACO-2	10513-107D9	94.45	6.59	1.28	0.18	1.10	0.18	0.73
colon carcinoma cell line:COLO-320	10420-106C6	31.93	3.42	3.04	0.00	0.00	1.14	0.00
colon, adult, donor1	10082-102B1	120.19	5.95	1.19	1.19	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	111.98	4.11	2.47	2.12	0.00	0.59	0.00
colon, fetal, donor1	10070-101I7	48.82	8.65	2.47	3.09	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	169.59	4.58	9.17	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	12.32	0.42	0.00	0.00	0.00	1.27	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	29.73	2.11	0.75	0.15	0.00	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	33.84	2.40	0.56	0.28	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	29.85	5.31	1.66	1.11	0.11	0.44	0.33
cruciate ligament, donor2	10295-104G7	39.71	2.43	3.24	0.00	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	28.09	8.83	2.41	2.41	0.00	0.00	0.00
diencephalon, adult	10193-103E4	17.52	2.88	1.68	4.80	0.96	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	16.76	1.84	2.76	0.23	0.00	2.53	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	192.59	6.92	16.16	2.05	9.23	1.03	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	58.50	1.44	3.13	0.24	0.24	0.00	1.20
ductus deferens, adult	10196-103E7	73.26	2.49	1.00	1.50	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	30.24	5.76	1.44	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	49.29	4.41	2.94	2.21	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	68.22	6.36	3.22	0.66	0.00	0.99	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	22.87	1.78	0.22	0.00	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	59.61	3.58	0.86	0.43	0.29	0.29	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	25.90	2.47	2.47	0.00	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	22.10	3.33	0.61	0.30	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	19.76	0.62	0.62	0.62	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	28.90	1.31	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	63.02	1.34	3.69	0.34	5.03	0.34	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	73.58	7.97	1.63	1.45	0.00	1.63	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	109.84	5.79	9.65	1.93	8.52	2.25	1.45
epidermoid carcinoma cell line:A431	10426-106D3	185.52	1.56	5.11	0.56	4.89	0.11	2.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	293.44	3.08	5.17	0.77	13.97	0.22	5.61
epididymis, adult	10197-103E8	81.42	6.70	4.81	1.26	4.40	0.42	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	64.75	4.08	1.60	0.53	0.18	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	27.53	0.00	1.97	0.39	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	40.49	4.19	1.70	1.97	0.13	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	36.32	2.56	1.28	2.07	0.10	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	46.38	3.47	1.57	1.01	0.00	0.34	0.22
esophagus, adult, pool1	10015-101C6	175.83	5.52	7.11	2.23	5.63	1.38	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	22.92	3.63	2.00	0.13	0.13	0.75	1.13
eye - muscle inferior rectus, donor1	10272-104E2	14.49	0.00	4.83	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	4.21	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	16.37	7.44	4.46	2.98	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	27.52	2.29	0.00	2.29	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	1.46	0.00	1.46	1.46	1.46	1.46
eye, fetal, donor1	10054-101G9	32.03	4.58	1.02	0.25	0.51	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	38.34	2.18	0.64	0.38	0.00	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	32.29	3.56	0.71	0.47	0.00	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	34.62	7.41	1.60	5.16	1.31	0.56	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	99.38	5.70	2.40	0.30	7.81	0.30	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	69.31	1.92	1.92	0.18	0.18	0.27	0.09
gall bladder, adult	10198-103E9	112.99	3.62	4.10	1.45	1.45	0.48	0.97
gamma delta positive T cells, donor1	11937-126A2	75.16	6.44	3.22	0.00	0.00	8.59	0.00
gamma delta positive T cells, donor2	11938-126A3	84.04	2.99	6.35	0.37	0.00	4.11	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	39.29	2.96	1.27	2.11	0.00	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	64.79	3.87	0.77	0.00	0.00	0.97	0.77
gastric cancer cell line:AZ521	10549-107H9	54.43	7.38	0.82	0.98	0.33	0.66	0.33
gastric cancer cell line:GSS	10560-108A2	46.68	11.90	0.92	1.83	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	14.16	4.80	2.28	0.46	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	12.28	0.34	0.46	0.23	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	91.39	2.24	2.94	0.00	0.28	0.56	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	82.31	6.24	4.49	0.75	2.00	0.50	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	71.46	2.22	0.95	0.74	0.00	0.11	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	63.76	2.11	0.28	0.98	0.42	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	69.87	3.09	0.66	0.99	0.00	0.44	0.11
glioma cell line:GI-1	10413-106B8	51.84	4.98	1.46	0.59	0.00	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	10.20	3.64	0.00	2.19	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	36.61	4.15	2.20	1.46	0.00	0.73	0.00
globus pallidus, adult, donor10258	10367-105F7	15.06	5.48	1.37	1.37	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	15.99	2.13	0.00	2.13	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	137.04	0.00	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	53.12	3.52	0.32	1.92	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	33.97	12.40	3.21	0.46	16.99	0.92	4.59
hIPS +CCl2, biol_rep2	14384-156C1	41.15	10.52	2.74	0.46	12.35	0.00	3.66
hIPS +CCl2, biol_rep3	14385-156C2	39.93	14.81	1.93	0.00	9.02	0.64	5.15
hIPS, biol_rep1	14380-156B6	21.56	21.56	7.19	0.00	0.00	0.00	4.31
hIPS, biol_rep2	14381-156B7	33.61	10.97	3.43	0.00	6.86	0.00	5.49
hIPS, biol_rep3	14382-156B8	11.03	7.72	0.00	4.41	1.10	1.10	2.21
hairy cell leukemia cell line:Mo	10712-109I1	31.61	2.30	2.87	0.29	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	43.65	2.99	0.30	1.49	0.00	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	32.42	2.35	1.57	0.78	0.00	0.78	0.00
heart - tricuspid valve, adult	10207-103F9	16.65	1.67	0.00	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	85.09	5.71	2.86	1.43	1.84	1.22	1.43
heart, adult, diseased, donor1	10051-101G6	48.12	3.83	1.70	2.55	0.00	0.85	0.00
heart, adult, pool1	10016-101C7	54.73	5.98	2.30	2.30	0.00	1.84	0.00
heart, fetal, pool1	10046-101G1	50.11	6.16	1.44	0.72	0.00	2.05	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	38.57	0.93	0.31	0.93	0.00	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	14.27	3.57	0.00	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	37.90	5.19	1.33	0.44	0.33	0.77	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	40.78	6.55	1.82	1.09	0.73	0.49	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	47.29	7.48	1.62	0.81	0.61	0.10	0.30
hepatoma cell line:Li-7	10484-107A7	38.70	5.00	0.78	0.33	0.00	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	42.91	3.82	2.81	0.10	0.00	0.70	0.00
hippocampus - adult, donor10196	10169-103B7	15.14	5.68	1.89	5.68	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	24.70	6.94	2.25	2.25	0.82	0.82	0.00
hippocampus, adult, donor10258	10374-105G5	14.44	5.48	1.00	5.48	1.99	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	27.14	3.17	1.41	3.17	0.00	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	52.49	10.99	4.27	0.00	23.19	1.22	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	62.24	9.62	2.16	0.20	13.55	0.98	2.95
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	63.98	14.47	0.76	0.25	13.46	1.02	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	19.74	10.71	1.69	0.00	1.69	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	26.08	11.10	0.77	0.00	1.55	0.00	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	22.40	14.05	0.38	0.00	1.90	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	22.77	11.09	0.58	0.00	2.63	0.58	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	25.42	8.40	0.86	0.22	1.51	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	29.61	9.59	0.00	0.00	0.83	0.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	32.68	8.76	1.66	0.00	0.95	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.61	6.59	0.64	0.32	0.96	0.64	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	34.34	10.10	0.67	0.00	0.67	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	50.23	9.70	1.56	0.00	7.98	1.72	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	46.18	13.26	2.46	0.98	13.26	1.47	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	29.67	6.98	0.00	0.00	7.85	0.00	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	25.01	14.32	0.76	0.00	0.76	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	29.22	9.16	0.44	0.00	0.44	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	17.99	13.99	1.00	0.00	0.50	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.96	4.33	0.38	0.00	0.38	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	21.83	8.18	1.36	0.00	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	25.37	7.52	0.63	0.00	0.94	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	29.56	8.65	0.82	0.16	1.14	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	28.74	9.87	1.16	0.00	0.58	0.58	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	36.47	11.36	0.60	0.00	1.20	0.30	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	62.44	12.56	1.85	0.55	9.98	0.55	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	51.64	12.27	2.28	0.00	7.99	1.43	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	48.18	10.21	3.27	0.41	17.15	1.63	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	38.73	10.56	1.76	0.00	3.52	0.70	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	36.43	14.89	0.00	0.00	2.22	0.32	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	46.00	12.41	0.00	0.00	0.91	0.91	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	41.37	10.34	1.03	0.00	1.55	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	34.54	7.97	0.66	0.00	0.66	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	34.63	9.75	0.51	0.00	1.28	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	35.02	7.16	0.51	0.00	0.26	0.00	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	30.29	19.69	0.00	0.00	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	37.30	10.08	0.67	0.00	1.01	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	59.89	14.73	1.45	0.24	10.87	0.97	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	60.61	12.92	3.12	0.00	9.80	0.89	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	58.05	13.17	3.90	0.00	13.17	1.46	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	27.51	15.28	0.31	0.31	0.31	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	3.25	3.25	0.00	6.51	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	23.83	11.58	0.33	0.00	0.99	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	26.82	10.40	2.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	30.40	10.86	0.72	0.00	2.90	0.72	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	23.13	8.90	0.36	0.36	1.42	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	33.41	10.74	0.00	0.00	0.00	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	38.19	12.87	1.63	0.00	0.68	0.41	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	29.36	7.27	1.08	0.00	0.00	0.00	0.81
immature langerhans cells, donor1	11904-125F5	23.97	6.54	1.45	0.00	0.24	0.24	0.00
immature langerhans cells, donor2	11905-125F6	52.28	11.88	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	36.91	7.10	3.03	6.44	1.23	1.14	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	125.18	2.60	2.28	0.65	4.55	0.98	0.00
kidney, adult, pool1	10017-101C8	76.70	7.61	3.80	1.70	0.40	1.10	0.20
kidney, fetal, pool1	10045-101F9	67.13	14.43	3.54	1.70	0.99	1.27	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	50.84	5.54	2.13	0.85	0.14	1.70	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	16.73	2.76	0.41	0.14	0.00	0.55	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	38.35	1.47	1.10	0.37	0.55	0.37	0.18
left atrium, adult, donor1	10079-102A7	16.35	3.27	0.54	3.27	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	23.77	3.03	0.00	3.03	0.00	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	30.92	3.01	1.37	1.92	0.00	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	94.12	2.16	1.08	2.51	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	97.83	2.72	0.00	2.17	0.00	0.00	1.09
leiomyoma cell line:15425	10571-108B4	104.90	2.67	1.46	1.94	0.24	0.00	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	75.28	2.09	0.00	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	98.70	1.53	1.77	0.59	0.00	0.12	0.47
liposarcoma cell line:KMLS-1	10782-110G8	51.39	2.97	1.41	0.31	0.16	0.16	0.00
liposarcoma cell line:SW 872	10726-110A6	76.64	7.68	0.49	1.58	0.12	0.73	0.49
liver, adult, pool1	10018-101C9	37.92	4.54	6.16	4.21	0.00	0.49	0.00
liver, fetal, pool1	10086-102B5	24.46	2.82	1.88	0.94	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	21.44	5.10	2.04	3.35	1.90	0.73	0.15
locus coeruleus, adult, donor10252	10165-103B3	23.81	4.80	1.11	1.11	1.48	0.92	0.55
locus coeruleus, adult, donor10258	10375-105G6	23.98	6.49	0.85	3.10	0.56	1.69	0.28
locus coeruleus, newborn, donor10223	10362-105F2	12.20	4.63	2.10	1.68	0.84	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	51.62	4.29	1.11	0.69	0.14	0.28	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	168.90	2.76	2.76	0.69	2.76	0.69	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	199.57	9.23	2.50	0.40	5.67	0.40	1.05
lung, adult, pool1	10019-101D1	67.69	2.48	2.84	0.35	0.59	1.54	0.00
lung, fetal, donor1	10068-101I5	37.39	7.71	2.57	0.29	0.00	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	55.44	3.67	0.92	0.92	0.00	0.92	0.92
lymph node, adult, donor1	10077-102A5	36.92	8.99	1.42	0.00	0.00	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	18.63	1.32	2.41	0.44	0.00	2.85	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	37.73	7.24	6.19	0.30	0.00	2.72	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	156.31	1.70	5.10	0.85	9.34	0.00	0.00
mature adipocyte, donor1	12231-129F8	36.41	5.33	1.78	0.89	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	23.04	4.77	0.83	1.04	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	30.34	6.64	2.13	1.66	0.00	0.24	0.00
mature adipocyte, donor4	12234-129G2	24.22	4.74	1.84	0.53	0.00	1.05	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	40.50	8.34	1.43	1.19	1.67	1.19	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	12.41	4.51	2.26	2.26	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	27.22	5.15	1.66	6.80	1.10	1.66	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	20.65	5.08	0.95	4.13	2.86	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	7.68	4.26	1.71	4.26	1.28	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	16.20	2.53	1.18	4.56	0.84	1.01	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	28.65	6.15	1.49	3.18	1.27	0.64	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	3.85	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	17.23	11.13	1.79	5.74	1.08	0.36	2.51
medulla oblongata - adult, donor10196	10174-103C3	9.09	5.19	1.95	0.65	0.65	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	27.09	3.87	0.93	2.17	1.39	1.08	0.15
medulla oblongata, adult, pool1	10038-101F2	39.43	6.53	3.10	2.78	1.71	1.31	0.41
medulla oblongata, newborn, donor10223	10361-105F1	30.20	9.03	0.35	1.39	0.35	1.04	0.35
medulloblastoma cell line:D283 Med	10838-111E1	18.82	2.88	0.22	0.00	0.00	0.89	0.44
medulloblastoma cell line:ONS-76	10759-110E3	39.01	1.96	1.35	0.73	0.12	0.61	0.37
melanoma cell line:COLO 679	10514-107E1	54.34	1.72	1.58	0.57	0.00	0.72	0.00
melanoma cell line:G-361	10465-106H6	35.56	0.81	1.09	0.54	0.00	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	74.53	1.45	0.54	0.54	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	40.53	2.64	0.88	0.00	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	34.22	0.78	1.81	0.00	4.15	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	87.76	3.38	0.61	1.23	0.15	0.31	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	45.45	3.09	0.36	1.09	0.00	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	71.64	5.80	1.66	1.66	0.00	0.00	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	42.56	1.83	1.40	1.97	0.00	0.42	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	45.83	3.08	0.77	0.96	0.00	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.87	3.47	2.08	0.69	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	53.21	2.23	0.17	1.37	0.17	0.00	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	72.00	2.88	0.35	2.53	0.00	0.12	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	85.82	2.25	0.53	1.86	0.13	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	79.40	3.78	0.41	1.35	0.27	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	86.07	1.71	0.43	3.13	0.43	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	29.31	2.96	0.66	0.99	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	83.16	4.15	0.28	3.32	0.00	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	146.96	3.49	0.00	0.70	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	63.90	1.43	0.41	1.84	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	59.31	1.80	2.16	1.08	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	59.48	2.59	0.31	1.76	0.10	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	93.02	1.37	0.23	2.05	0.23	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	65.45	2.10	1.68	1.26	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	55.89	2.54	0.90	2.69	0.00	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	87.36	2.71	0.18	1.84	0.09	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	49.33	1.47	0.00	1.47	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	74.40	3.15	2.29	0.57	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	49.26	3.79	2.95	0.84	0.00	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	68.50	6.85	0.91	0.91	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	92.08	4.35	2.81	0.51	0.26	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	79.31	6.02	0.79	1.05	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	82.57	4.31	0.62	0.62	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	78.61	5.88	0.94	1.18	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	80.21	7.11	1.35	0.68	0.00	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	78.59	4.32	0.79	0.79	0.00	0.39	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	75.53	4.63	2.32	0.93	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	98.64	5.48	1.73	1.15	0.00	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	86.34	4.69	1.12	0.00	0.00	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	84.84	3.85	0.96	0.48	0.00	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	66.73	5.87	0.00	0.73	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	81.23	5.71	2.35	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	87.20	2.87	2.05	1.23	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	77.32	5.58	1.29	0.86	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	71.09	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	70.80	5.52	0.97	1.30	0.32	0.00	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	65.47	5.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	79.43	7.46	1.60	1.07	0.00	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	82.59	2.45	0.82	0.82	0.00	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	80.08	3.89	0.78	0.78	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	58.76	4.20	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	73.52	0.99	0.99	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	68.78	6.52	1.78	1.19	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	76.76	6.09	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	88.67	5.70	0.00	1.90	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	44.49	4.83	0.69	1.72	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	36.54	8.60	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	7.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	30.97	2.85	1.22	1.22	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	37.34	3.97	0.00	3.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	34.19	0.59	0.00	0.59	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	31.48	3.12	0.62	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	34.75	9.36	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	35.48	2.37	2.37	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	43.66	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	36.49	2.75	2.07	1.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	22.27	8.91	0.99	0.49	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	10.09	3.36	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	20.35	7.00	0.64	1.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	20.96	7.66	0.40	0.40	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	8.72	2.18	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	6.34	0.00	0.00	0.00	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.96	5.46	1.21	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	13.56	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.94	4.94	0.00	1.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	30.95	5.36	1.59	0.60	0.00	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	32.45	7.14	0.97	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	43.80	3.06	2.04	0.00	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	48.74	3.09	0.77	0.00	0.00	2.32	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	48.43	1.42	2.36	1.42	0.00	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	78.07	2.78	0.23	1.39	1.16	0.00	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	57.23	1.34	0.82	1.23	0.00	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	20.43	1.59	1.82	0.00	0.23	0.45	0.00
mesothelioma cell line:Mero-41	10851-111F5	53.30	1.71	1.22	0.98	0.00	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	88.35	3.76	0.44	0.66	0.66	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	37.58	1.58	0.26	0.26	0.26	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	56.17	2.55	1.02	1.53	0.00	0.00	0.17
mesothelioma cell line:Mero-84	10855-111F9	78.11	0.76	0.76	1.01	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	81.16	5.59	0.21	1.45	0.83	0.21	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	159.68	3.98	0.00	1.99	0.00	0.00	1.99
mesothelioma cell line:NCI-H226	10846-111E9	69.86	1.27	0.00	1.09	0.18	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	81.31	0.68	0.17	1.20	0.51	0.00	0.34
mesothelioma cell line:NCI-H28	10845-111E8	48.60	2.80	1.02	0.76	0.25	0.51	0.51
mesothelioma cell line:No36	10857-111G2	15.98	3.59	0.65	0.00	0.00	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	57.17	0.81	0.54	1.63	0.00	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	35.12	7.68	3.45	0.58	0.00	1.54	0.00
migratory langerhans cells, donor2	11902-125F3	76.08	13.55	3.54	0.85	0.00	2.08	0.00
migratory langerhans cells, donor3	11903-125F4	57.07	9.33	2.87	1.08	0.00	3.23	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	23.51	1.96	0.98	0.98	0.33	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.27	3.60	0.21	0.64	0.00	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	230.82	2.53	1.84	0.46	14.05	0.00	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	43.01	2.09	0.95	0.38	0.00	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	63.94	1.48	1.11	0.74	0.00	1.11	0.00
myeloma cell line:PCM6	10474-106I6	58.71	0.79	0.99	0.20	0.00	0.79	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	51.24	1.52	1.52	4.06	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	71.20	0.59	1.18	1.57	0.00	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	78.78	1.78	3.68	0.33	1.45	0.11	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	65.01	0.44	2.94	0.07	1.10	0.29	0.15
nasal epithelial cells, donor2	12227-129F4	123.65	0.55	2.21	0.55	3.31	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	25.54	6.44	0.69	0.23	0.23	1.38	0.23
neuroblastoma cell line:NB-1	10539-107G8	0.75	0.37	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	30.16	1.48	1.48	0.00	0.00	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	18.64	7.27	0.19	0.00	0.00	1.12	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.86	3.08	1.19	0.00	0.00	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	35.32	3.17	1.58	0.32	0.00	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	46.69	1.81	1.81	0.00	0.00	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	24.79	1.27	0.64	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	49.77	3.19	0.00	1.33	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	133.87	0.00	29.75	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	33.49	7.10	2.54	0.00	0.00	2.03	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	56.84	7.20	3.20	0.80	0.80	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	53.54	5.45	1.28	0.64	0.00	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	72.26	4.73	2.89	1.05	0.26	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	35.06	4.50	1.31	5.34	0.66	0.66	0.09
occipital cortex - adult, donor10196	10172-103C1	10.30	4.12	0.00	8.24	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	33.81	4.03	2.15	5.64	0.00	1.07	0.00
occipital cortex, newborn, donor10223	10355-105E4	18.93	7.64	1.46	2.55	0.36	0.73	2.18
occipital lobe, adult, donor1	10076-102A4	22.30	4.46	1.57	7.35	1.84	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	36.47	23.17	0.86	3.43	0.00	1.72	0.00
occipital pole, adult, pool1	10036-101E9	38.08	5.99	2.37	11.35	1.42	0.79	0.08
olfactory region, adult	10195-103E6	22.35	4.78	1.15	2.48	1.15	0.38	0.19
optic nerve, donor1	10277-104E7	4.00	4.00	2.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	144.55	4.56	4.67	1.48	5.70	0.11	2.85
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	155.93	7.56	10.17	1.37	6.18	2.34	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	244.84	2.71	1.69	1.35	9.48	0.51	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	151.43	4.50	4.85	0.58	2.77	0.69	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	50.56	2.65	0.59	0.88	0.00	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	45.78	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	37.32	9.54	1.27	0.21	0.00	0.85	0.00
ovary, adult, pool1	10020-101D2	58.79	3.67	1.92	0.26	0.26	0.87	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.50	0.55	0.18	0.18	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	57.38	6.58	1.88	4.70	0.00	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	138.09	5.59	0.84	0.00	5.59	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	69.50	1.53	1.19	0.68	0.34	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	137.27	1.32	1.82	0.99	6.46	0.83	0.50
paracentral gyrus, adult, pool1	10035-101E8	30.02	4.39	2.01	9.52	1.19	0.92	0.09
parietal cortex, adult, donor10258	10373-105G4	19.08	2.20	2.20	5.14	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	13.17	6.58	0.94	3.76	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	27.08	5.99	1.71	5.99	1.14	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	35.51	4.32	3.08	9.52	0.79	0.44	0.09
parietal lobe, fetal, donor1	10072-101I9	36.85	9.70	1.94	5.82	0.00	2.91	0.00
parietal lobe, newborn, donor10223	10356-105E5	12.71	2.62	1.87	1.87	1.12	0.75	0.37
parotid gland, adult	10199-103F1	140.60	3.08	3.08	3.08	4.32	1.85	0.00
penis, adult	10200-103F2	47.80	4.83	4.83	1.07	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	26.59	1.12	0.93	0.37	0.00	0.74	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	539.07	18.94	13.11	1.17	34.53	2.48	12.09
pineal gland - adult, donor10196	10179-103C8	11.61	1.29	0.00	0.00	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	31.98	2.37	0.00	1.18	0.59	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	18.81	3.14	0.63	0.00	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	20.24	1.01	1.01	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	48.47	5.21	1.04	0.00	5.21	1.56	0.00
pituitary gland, adult, donor10258	10378-105G9	19.58	0.85	2.55	0.85	2.55	2.55	0.00
placenta, adult, pool1	10021-101D3	100.19	3.33	5.27	0.43	1.51	0.86	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	14.70	1.72	2.25	0.00	0.00	1.46	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	31.59	0.93	0.31	0.16	0.16	0.31	0.00
pons, adult, pool1	10033-101E6	41.66	4.39	3.79	5.51	3.70	0.60	0.34
postcentral gyrus, adult, pool1	10032-101E5	38.18	6.63	2.18	12.03	1.31	1.31	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	121.30	6.27	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	59.43	2.04	3.06	0.58	0.00	0.58	0.00
prostate cancer cell line:PC-3	10439-106E7	157.00	4.17	3.27	1.27	2.18	0.54	1.45
prostate, adult, pool1	10022-101D4	80.08	4.44	2.90	0.91	1.36	0.45	0.18
putamen, adult, donor10196	10176-103C5	21.25	4.01	1.42	2.60	1.42	0.24	0.00
putamen, adult, donor10252	10152-102I8	33.33	3.92	0.00	1.96	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	1.09	2.19	2.19	2.19	2.19	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	21.99	2.42	0.97	8.21	0.24	0.48	0.00
putamen, newborn, donor10223	10365-105F5	6.75	1.50	2.25	0.00	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	64.59	2.91	1.75	0.58	2.04	0.58	0.00
rectum, fetal, donor1	10067-101I4	59.81	16.69	1.39	0.00	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	69.54	1.91	0.64	0.00	0.21	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	41.42	0.00	0.83	0.00	0.00	0.83	0.41
retina, adult, pool1	10030-101E3	53.68	7.95	1.79	0.89	0.30	1.19	0.00
retinoblastoma cell line:Y79	10475-106I7	23.38	4.16	1.04	0.00	1.04	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	62.58	3.57	2.34	0.37	0.98	0.25	1.48
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	48.65	3.09	2.53	0.28	0.00	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	62.90	3.79	0.76	0.76	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	52.12	0.32	2.27	0.16	1.13	0.16	0.16
salivary acinar cells, donor2	11772-123I8	72.84	1.10	4.13	1.24	1.38	0.96	0.00
salivary acinar cells, donor3	11773-123I9	69.52	1.32	3.97	2.65	2.65	1.99	0.00
salivary gland, adult, pool1	10093-102C3	85.22	3.43	4.58	8.01	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	55.73	1.77	1.60	1.85	0.08	0.67	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	52.31	2.47	2.12	1.88	0.00	0.47	0.00
seminal vesicle, adult	10201-103F3	77.24	2.12	0.53	0.00	1.06	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	178.79	10.20	5.34	0.24	9.96	0.97	3.40
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	39.00	4.78	3.27	0.50	0.25	1.26	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	72.25	3.01	6.02	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	49.83	4.70	2.01	0.13	1.61	0.81	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	89.75	2.21	2.98	1.44	2.76	0.22	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	109.28	2.97	1.68	1.55	1.55	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	13.48	2.13	6.38	2.13	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	29.14	2.40	10.07	1.20	0.00	1.20	0.36
skeletal muscle, fetal, donor1	10066-101I3	28.14	7.04	0.00	2.01	0.00	3.02	0.00
skin, adult, donor1	10074-102A2	61.07	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	46.08	9.47	0.63	3.16	1.89	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	58.70	6.67	2.33	0.33	1.00	1.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	49.17	10.72	5.99	0.32	2.84	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.79	38.94	0.58	0.19	0.00	0.77	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	35.11	1.48	3.30	0.00	0.82	0.49	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	9.65	4.50	1.13	0.00	0.00	0.64	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	57.75	5.23	2.18	0.65	1.96	0.44	0.22
small intestine, adult, pool1	10024-101D6	186.93	5.26	3.58	3.11	0.24	1.07	0.12
small intestine, fetal, donor1	10064-101I1	55.77	1.97	0.00	0.98	0.25	0.98	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	52.83	3.59	3.59	0.00	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	39.54	1.55	2.58	1.55	0.00	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	41.81	3.75	3.48	0.00	0.27	1.61	0.00
spinal cord - adult, donor10196	10181-103D1	15.14	2.52	0.69	1.61	0.00	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	28.78	5.91	0.00	0.39	0.00	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	8.99	3.46	2.08	1.38	0.00	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	39.64	12.81	1.83	3.05	0.00	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	19.29	4.59	5.05	2.76	0.00	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	55.41	3.14	0.60	1.79	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	53.53	4.19	3.96	1.43	0.00	3.19	0.00
spleen, fetal, pool1	10044-101F8	60.31	7.95	2.94	1.03	0.00	1.83	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	41.40	2.07	3.93	0.21	0.00	1.04	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	102.91	2.28	0.95	0.19	4.75	0.19	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	128.95	6.29	6.29	2.45	3.15	0.35	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	215.01	1.17	4.30	1.56	21.11	0.39	3.13
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	214.09	6.64	3.94	1.24	19.14	0.79	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	58.03	4.24	1.69	0.42	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	56.69	3.38	0.85	0.00	0.00	0.85	0.00
stomach, fetal, donor1	10062-101H8	39.52	7.48	2.14	0.00	2.14	0.00	1.07
submaxillary gland, adult	10202-103F4	94.57	3.42	3.42	1.14	1.14	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	20.36	2.28	0.42	0.00	0.21	0.62	0.00
substantia nigra, adult, donor10258	10371-105G2	15.00	6.21	1.03	2.07	1.03	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	19.08	3.53	1.41	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	40.12	6.19	0.00	0.92	0.00	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	42.89	6.02	3.14	9.75	1.44	1.02	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	32.76	19.23	2.85	2.14	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	39.56	27.69	3.52	1.76	0.00	1.32	0.00
tenocyte, donor1	11763-123H8	67.03	5.24	1.05	1.40	0.35	1.05	0.00
tenocyte, donor2	11765-123I1	53.41	5.72	0.76	0.76	0.00	0.38	0.38
tenocyte, donor3	11768-123I4	75.99	3.34	1.85	1.11	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	25.66	2.04	2.89	0.17	1.53	1.02	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	24.05	5.09	0.31	0.00	0.00	0.62	0.46
teratocarcinoma cell line:PA-1	10807-111A6	31.31	5.42	0.93	0.15	0.31	0.77	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	57.25	5.33	2.67	0.13	3.43	0.63	2.16
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	27.61	5.67	1.13	0.00	14.37	1.89	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	37.08	2.51	1.42	0.11	8.07	0.22	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	19.54	3.91	0.65	0.00	0.98	1.30	0.33
testis, adult, pool1	10026-101D8	36.51	2.90	1.72	1.50	0.32	0.32	0.00
testis, adult, pool2	10096-102C6	16.69	0.90	0.90	0.45	0.00	0.45	0.00
thalamus - adult, donor10196	10168-103B6	11.04	4.42	6.62	0.00	2.21	2.21	0.00
thalamus, adult, donor10252	10154-103A1	24.38	2.97	0.94	0.47	0.16	0.47	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	6.16	3.08	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.08	5.60	1.15	2.96	0.33	0.99	0.16
thalamus, newborn, donor10223	10366-105F6	15.53	2.88	2.30	1.15	4.03	1.15	0.58
throat, adult	10209-103G2	114.60	5.99	3.99	1.50	2.00	1.25	0.00
throat, fetal, donor1	10061-101H7	48.14	9.45	2.74	0.91	0.61	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	32.00	2.38	1.19	0.60	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	102.10	4.57	2.09	0.20	0.20	1.39	0.00
thymus, fetal, pool1	10043-101F7	80.01	3.95	1.87	0.31	1.04	2.49	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	107.70	4.65	1.06	0.27	0.13	0.13	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	40.65	2.65	1.40	0.84	0.28	1.12	0.00
thyroid, adult, pool1	10028-101E1	120.28	7.28	4.67	0.47	1.31	2.15	0.47
thyroid, fetal, donor1	10060-101H6	63.81	11.34	2.37	0.79	1.32	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	83.15	3.08	3.08	3.08	9.24	0.00	0.00
tongue, adult	10203-103F5	124.43	4.42	4.19	0.93	3.49	0.70	0.23
tongue, fetal, donor1	10059-101H5	47.69	7.49	4.34	0.00	1.18	0.79	0.00
tonsil, adult, pool1	10047-101G2	180.52	8.31	8.01	2.70	5.71	2.80	0.80
trachea, adult, pool1	10029-101E2	117.71	4.91	4.83	1.15	3.27	1.64	0.49
trachea, fetal, donor1	10058-101H4	51.55	11.16	3.08	1.54	2.31	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	105.22	1.77	0.35	1.06	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	122.29	1.52	2.53	0.30	6.38	0.20	1.62
transitional-cell carcinoma cell line:JMSU1	10492-107B6	39.96	2.35	2.04	1.72	0.00	0.63	0.00
tridermal teratoma cell line:HGRT	10694-109G1	100.83	0.00	1.90	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	53.92	4.32	0.85	0.34	0.51	0.25	0.25
umbilical cord, fetal, donor1	10057-101H3	70.94	6.26	6.26	2.09	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	46.07	6.83	3.58	0.85	0.68	1.02	0.17
uterus, fetal, donor1	10055-101H1	48.12	13.31	0.51	2.05	1.54	1.54	0.00
vagina, adult	10204-103F6	50.40	1.94	0.65	0.00	1.29	0.00	0.00
vein, adult	10191-103E2	47.79	3.29	2.41	0.22	0.00	1.75	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	45.93	2.67	4.27	1.34	0.00	0.53	0.27